

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>The relationship between mucosal immunity,... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-1568/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-1568" />
    
            <meta name="description" content="Read the original article in full on F1000Research: The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis" />
    
            <meta name="og:title" content="F1000Research Article: The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of &lt;i&gt;Bordetella pertussis&lt;/i&gt;.">
            <meta name="og:description" content="Read the latest article version by Christopher J. Gill, Pejman Rohani, Donald M Thea, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="12588">
            <meta name="article-id" content="11654">
            <meta name="dc.title" content="The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of &lt;i&gt;Bordetella pertussis&lt;/i&gt;">
            <meta name="dc.description" content="The incidence of whooping cough in the US has been rising slowly since the 1970s, but the pace of this has accelerated sharply since acellular pertussis vaccines replaced the earlier whole cell vaccines in the late 1990s. A similar trend occurred in many other countries, including the UK, Canada, Australia, Ireland, and Spain, following the switch to acellular vaccines. The key question is why. Two leading theories (short duration of protective immunologic persistence and evolutionary shifts in the pathogen to evade the vaccine) explain some but not all of these shifts, suggesting that other factors may also be important. 
In this synthesis, we argue that sterilizing mucosal immunity that blocks or abbreviates the duration of nasopharyngeal carriage of Bordetella pertussis and impedes person-to-person transmission (including between asymptomatically infected individuals) is a critical factor in this dynamic. Moreover, we argue that the ability to induce such mucosal immunity is fundamentally what distinguishes whole cell and acellular pertussis vaccines and may be pivotal to understanding much of the resurgence of this disease in many countries that adopted acellular vaccines. Additionally, we offer the hypothesis that observed herd effects generated by acellular vaccines may reflect a modification of disease presentation leading to reduced potential for transmission by those already infected, as opposed to inducing resistance to infection among those who have been exposed.">
            <meta name="dc.subject" content="whooping cough, acellular pertussis vaccine, bordetella pertussis">
            <meta name="dc.creator" content="Gill, Christopher J.">
            <meta name="dc.creator" content="Rohani, Pejman">
            <meta name="dc.creator" content="Thea, Donald M">
            <meta name="dc.date" content="2017/08/25">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11654.1">
            <meta name="dc.source" content="F1000Research 2017 6:1568">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="whooping cough">
            <meta name="prism.keyword" content="acellular pertussis vaccine">
            <meta name="prism.keyword" content="bordetella pertussis">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/08/25">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="1568">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11654.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-1568">
            <meta name="citation_title" content="The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of &lt;i&gt;Bordetella pertussis&lt;/i&gt;">
            <meta name="citation_abstract" content="The incidence of whooping cough in the US has been rising slowly since the 1970s, but the pace of this has accelerated sharply since acellular pertussis vaccines replaced the earlier whole cell vaccines in the late 1990s. A similar trend occurred in many other countries, including the UK, Canada, Australia, Ireland, and Spain, following the switch to acellular vaccines. The key question is why. Two leading theories (short duration of protective immunologic persistence and evolutionary shifts in the pathogen to evade the vaccine) explain some but not all of these shifts, suggesting that other factors may also be important. 
In this synthesis, we argue that sterilizing mucosal immunity that blocks or abbreviates the duration of nasopharyngeal carriage of Bordetella pertussis and impedes person-to-person transmission (including between asymptomatically infected individuals) is a critical factor in this dynamic. Moreover, we argue that the ability to induce such mucosal immunity is fundamentally what distinguishes whole cell and acellular pertussis vaccines and may be pivotal to understanding much of the resurgence of this disease in many countries that adopted acellular vaccines. Additionally, we offer the hypothesis that observed herd effects generated by acellular vaccines may reflect a modification of disease presentation leading to reduced potential for transmission by those already infected, as opposed to inducing resistance to infection among those who have been exposed.">
            <meta name="citation_description" content="The incidence of whooping cough in the US has been rising slowly since the 1970s, but the pace of this has accelerated sharply since acellular pertussis vaccines replaced the earlier whole cell vaccines in the late 1990s. A similar trend occurred in many other countries, including the UK, Canada, Australia, Ireland, and Spain, following the switch to acellular vaccines. The key question is why. Two leading theories (short duration of protective immunologic persistence and evolutionary shifts in the pathogen to evade the vaccine) explain some but not all of these shifts, suggesting that other factors may also be important. 
In this synthesis, we argue that sterilizing mucosal immunity that blocks or abbreviates the duration of nasopharyngeal carriage of Bordetella pertussis and impedes person-to-person transmission (including between asymptomatically infected individuals) is a critical factor in this dynamic. Moreover, we argue that the ability to induce such mucosal immunity is fundamentally what distinguishes whole cell and acellular pertussis vaccines and may be pivotal to understanding much of the resurgence of this disease in many countries that adopted acellular vaccines. Additionally, we offer the hypothesis that observed herd effects generated by acellular vaccines may reflect a modification of disease presentation leading to reduced potential for transmission by those already infected, as opposed to inducing resistance to infection among those who have been exposed.">
            <meta name="citation_keywords" content="whooping cough, acellular pertussis vaccine, bordetella pertussis">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Christopher J. Gill">
            <meta name="citation_author_institution" content="Centre for Global Health and Development , Boston University School of Public Health, Boston, Massachusetts, 02118, USA">
            <meta name="citation_author_institution" content="Department of Global Health, Boston University School of Public Health, Boston, Massachusetts,  02118, USA">
            <meta name="citation_author" content="Pejman Rohani">
            <meta name="citation_author_institution" content="Department of Infectious Diseases College of Veterinary Medicine, Odum School of Ecology , University of Georgia, Athens, Georgia, 30602, USA">
            <meta name="citation_author" content="Donald M Thea">
            <meta name="citation_author_institution" content="Centre for Global Health and Development , Boston University School of Public Health, Boston, Massachusetts, 02118, USA">
            <meta name="citation_author_institution" content="Department of Global Health, Boston University School of Public Health, Boston, Massachusetts,  02118, USA">
            <meta name="citation_publication_date" content="2017/08/25">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="1568">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11654.1">
            <meta name="citation_firstpage" content="1568">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-1568/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-1568.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=12588 /> <input type=hidden id=articleId name=articleId value=11654 /> <input type=hidden id=xmlUrl value="/articles/6-1568/v1/xml"/> <input type=hidden id=xmlFileName value="-6-1568-v1.xml"> <input type=hidden id=article_uuid value=5d1ff47b-1f1d-4ed8-8951-bfbb1888e418 /> <input type=hidden id=referer value=""/> <input type="hidden" id="meta-article-title" value="The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of <i>Bordetella pertussis</i>" /> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11654.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11654.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-1568"
  },
  "headline": "The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the...",
  "datePublished": "2017-08-25T14:40:04",
  "dateModified": "2017-08-25T14:40:04",
  "author": [
    {
      "@type": "Person",
      "name": "Christopher J. Gill"
    },    {
      "@type": "Person",
      "name": "Pejman Rohani"
    },    {
      "@type": "Person",
      "name": "Donald M Thea"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "The incidence of whooping cough in the US has been rising slowly since the 1970s, but the pace of this has accelerated sharply since acellular pertussis vaccines replaced the earlier whole cell vaccines in the late 1990s. A similar trend occurred in many other countries, including the UK, Canada, Australia, Ireland, and Spain, following the switch to acellular vaccines. The key question is why. Two leading theories (short duration of protective immunologic persistence and evolutionary shifts in the pathogen to evade the vaccine) explain some but not all of these shifts, suggesting that other factors may also be important.
In this synthesis, we argue that sterilizing mucosal immunity that blocks or abbreviates the duration of nasopharyngeal carriage of Bordetella pertussis and impedes person-to-person transmission (including between asymptomatically infected individuals) is a critical factor in this dynamic. Moreover, we argue that the ability to induce such mucosal immunity is fundamentally what distinguishes whole cell and acellular pertussis vaccines and may be pivotal to understanding much of the resurgence of this disease in many countries that adopted acellular vaccines. Additionally, we offer the hypothesis that observed herd effects generated by acellular vaccines may reflect a modification of disease presentation leading to reduced potential for transmission by those already infected, as opposed to inducing resistance to infection among those who have been exposed."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-1568.html",
            "name": "The relationship between mucosal immunity, nasopharyngeal carriage,..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> The relationship between mucosal immunity, nasopharyngeal carriage,... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=12588 data-id=11654 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11654.1" data-recommended="" data-doi="10.12688/f1000research.11654.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-1568/v1/pdf?article_uuid=5d1ff47b-1f1d-4ed8-8951-bfbb1888e418" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11654-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11654-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11654-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Gill CJ, Rohani P and Thea DM. The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of <i>Bordetella pertussis</i> [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1568 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11654.1" target=_blank>https://doi.org/10.12688/f1000research.11654.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11654-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11654 id=track-article-signin-11654 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11654?target=/articles/6-1568.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12588 /> <input name=articleId type=hidden value=11654 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of <i>Bordetella pertussis</i></h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:cgill@bu.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Christopher J. Gill</span></a><a href="https://orcid.org/0000-0003-3353-0617" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-3353-0617</div><sup>1,2</sup>,&nbsp;</span><span class="">Pejman Rohani<sup>3</sup>,&nbsp;</span><span class="">Donald M Thea<sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:cgill@bu.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Christopher J. Gill</span></a><a href="http://orcid.org/0000-0003-3353-0617" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-3353-0617</div><sup>1,2</sup>,&nbsp;</span><span class="">Pejman Rohani<sup>3</sup>,&nbsp;</span><span class="">Donald M Thea<sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 25 Aug 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11654.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Centre for Global Health and Development , Boston University School of Public Health, Boston, Massachusetts, 02118, USA<br/> <sup>2</sup> Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, 02118, USA<br/> <sup>3</sup> Department of Infectious Diseases College of Veterinary Medicine, Odum School of Ecology , University of Georgia, Athens, Georgia, 30602, USA<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=25495-25384></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=25342-25385></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> The incidence of whooping cough in the US has been rising slowly since the 1970s, but the pace of this has accelerated sharply since acellular pertussis vaccines replaced the earlier whole cell vaccines in the late 1990s. A similar trend occurred in many other countries, including the UK, Canada, Australia, Ireland, and Spain, following the switch to acellular vaccines. The key question is why. Two leading theories (short duration of protective immunologic persistence and evolutionary shifts in the pathogen to evade the vaccine) explain some but not all of these shifts, suggesting that other factors may also be important.<br/> In this synthesis, we argue that sterilizing mucosal immunity that blocks or abbreviates the duration of nasopharyngeal carriage of <i>Bordetella pertussis</i> and impedes person-to-person transmission (including between asymptomatically infected individuals) is a critical factor in this dynamic. Moreover, we argue that the ability to induce such mucosal immunity is fundamentally what distinguishes whole cell and acellular pertussis vaccines and may be pivotal to understanding much of the resurgence of this disease in many countries that adopted acellular vaccines. Additionally, we offer the hypothesis that observed herd effects generated by acellular vaccines may reflect a modification of disease presentation leading to reduced potential for transmission by those already infected, as opposed to inducing resistance to infection among those who have been exposed. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> whooping cough, acellular pertussis vaccine, bordetella pertussis </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Christopher J. Gill (<a href="mailto:cgill@bu.edu">cgill@bu.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Christopher J. Gill </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Gill CJ <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Gill CJ, Rohani P and Thea DM. The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of <i>Bordetella pertussis</i> [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1568 (<a href="https://doi.org/10.12688/f1000research.11654.1" target=_blank>https://doi.org/10.12688/f1000research.11654.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 25 Aug 2017, <b>6</b>(F1000 Faculty Rev):1568 (<a href="https://doi.org/10.12688/f1000research.11654.1" target=_blank>https://doi.org/10.12688/f1000research.11654.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 25 Aug 2017, <b>6</b>(F1000 Faculty Rev):1568 (<a href="https://doi.org/10.12688/f1000research.11654.1" target=_blank>https://doi.org/10.12688/f1000research.11654.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d9873e197>Introduction</h2><p class="" id=d9873e200><i>Bordetella pertussis</i>, the principal agent of whooping cough, infects millions of children around the world and kills many thousands, with severe and fatal cases concentrated among very young infants<sup><a href="#ref-1">1</a>–<a href="#ref-3">3</a></sup>. Pertussis is arguably the least well prevented of the common vaccine-preventable childhood diseases<sup><a href="#ref-4">4</a></sup>. Why this may be so reflects gaps in our understanding of the immunology and epidemiology of this pathogen, how these variables are affected by pertussis vaccines, and the degree to which they affect the transmissibility of <i>B. pertussis</i>.</p><p class="" id=d9873e219>A significant, but surprisingly under-examined, unknown is whether an asymptomatic infection state exists for <i>B. pertussis</i>, as is the case for many other bacterial respiratory pathogens, notably <i>Streptococcus pneumoniae</i>, <i>Haemophilus influenzae</i> type B (HiB), and <i>Neisseria meningitidis</i>. Each of these pathogens proved amenable to control using protein–polysaccharide conjugate vaccines. An essential attribute of these vaccines is their ability to induce robust mucosal immunity that interferes with or blocks these bacteria from colonizing the nasopharynx and propagating on the respiratory mucosa, irrespective of whether those events lead to clinical disease<sup><a href="#ref-5">5</a>–<a href="#ref-7">7</a></sup>. But does <i>B. pertussis</i> exist in an asymptomatic infection state also? Can pertussis transmit from asymptomatic individuals? Do pertussis vaccines interfere with these processes? And, if so, how? These are fundamental unresolved questions. The resurgence of pertussis in the US to its highest levels since the 1940s<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup> emphasizes the need for answers to these questions (<a href="#f1">Figure 1</a>).</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/12588/41c45eee-9f54-43a4-9514-2a22b8b7190c_figure1.gif"><img alt="41c45eee-9f54-43a4-9514-2a22b8b7190c_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/12588/41c45eee-9f54-43a4-9514-2a22b8b7190c_figure1.gif"></a><div class=caption><h3>Figure 1. Trends in US pertussis incidence, 1940–2012.</h3><p id=d9873e265>This figure depicts the annual per-capita incidence of pertussis infections in the US over the past seven decades, with the timing of the introduction of whole cell (wP) and acellular (aP) vaccines noted in annotations. The inset at the top right expands the details and readjusts the scale relevant to the period of rising incidence. As can be seen, pertussis rates were slowly rising since the 1970s but accelerated sharply following the transition to aP vaccines in 1996. The data are truncated as of 2010, but the rise of pertussis incidence has continued since that time.</p></div></div><p class="" id=d9873e272>There is increasing consensus that earlier whole cell pertussis (wP) vaccines impeded infections (not just clinical disease), generating herd immunity<sup><a href="#ref-10">10</a>,<a href="#ref-11">11</a></sup>, which, if we can extrapolate from the examples of Hib, pneumococcus, and meningococcus, could plausibly occur by interfering with <i>B. pertussis</i> colonization of the respiratory mucosa. It was subsequently assumed that subunit acellular (aP) vaccines would share this characteristic, particularly for aP vaccines that included the adhesion protein antigens pertactin (PRN), filamentous hemagglutinin (FHA), and fimbriae proteins 2 and 3 (Fim2/3). However, longitudinal nasopharyngeal (NP) sampling studies were not conducted to directly assess whether and to what degree either wP or aP vaccines interfered with <i>B. pertussis</i> carriage. That leaves us challenged to explain the surprising failure of several contemporary pertussis control strategies. Notably, why is whooping cough increasing in the US despite record rates of pertussis vaccine uptake, a pattern repeated in many other countries that switched from wP to aP vaccines (<a href="#f2">Figure 2</a>)<sup><a href="#ref-12">12</a>–<a href="#ref-14">14</a></sup>, and why has the strategy of vaccinating the household contacts of newborns (“cocooning”) failed to prevent pertussis among young infants<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup>?</p><div class="fig panel clearfix"><a name=f2 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/12588/41c45eee-9f54-43a4-9514-2a22b8b7190c_figure2.gif"><img alt="41c45eee-9f54-43a4-9514-2a22b8b7190c_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/12588/41c45eee-9f54-43a4-9514-2a22b8b7190c_figure2.gif"></a><div class=caption><h3>Figure 2. Changes in pertussis incidence relative to the introduction of acellular pertussis vaccines in the US, UK, Australia, and Ireland.</h3><p id=d9873e317>Depicted are incidence data over time from the US, Australia, the United Kingdom (including Northern Ireland), and the Republic of Ireland. In each case, the introduction of acellular (aP) pertussis vaccines preceded an abrupt increase in disease incidence rates following a delay of 5–10 years. The declining incidence seen for the UK and Republic of Ireland from the early 1990s is likely explained by a reduction in whole cell pertussis vaccine uptake that occurred in the 1980s following several highly publicized adverse events that were attributed to pertussis vaccines.</p></div></div><p class="" id=d9873e324>In this analysis, we examine the evidence surrounding possible explanations for the resurgence of pertussis and explore why many prior hypotheses fail to adequately explain current disease trends. From this, we offer a synthesis of old and new evidence that we believe points to a fundamentally different explanation in which the failure of aP vaccines to induce robust mucosal immunity plays a pivotal role. In addition, we offer a novel hypothesis for how aP vaccines may achieve some degree of herd immunity that is delinked from effects on mucosal immunity.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d9873e330>The evidence</h2><div class=section><a name=d9873e333 class=n-a></a><h3 class=section-title>Mucosal immunity and its link to herd immunity against respiratory pathogens</h3><p class="" id=d9873e338>For the purposes of this manuscript, we define “mucosal immunity” as any process that leads to a protective immune response on a mucosal surface, even if the origin of that response may not reside locally within the mucosa itself. This definition therefore includes secreted antibody (IgA or IgG) that may derive from non-mucosal B-lymphocytes elsewhere in the body but which serve to interdict mucosal pathogens remotely.</p><p class="" id=d9873e341>Protein–polysaccharide conjugate vaccines targeting the trio of encapsulated respiratory pathogens HiB, <i>Streptococcus pneumoniae</i>, and <i>Neisseria meningitidis</i> have provided important insights into the mechanisms of vaccine-derived herd immunity<sup><a href="#ref-17">17</a>–<a href="#ref-23">23</a></sup>. In each case, the vaccines yielded steep reductions in disease among vaccinated and unvaccinated individuals, i.e. indirect herd effects, and, for each, the critical mechanism yielding herd effects proved to be a reduction in NP colonization rates, in turn mediated by sterilizing mucosal immunity<sup><a href="#ref-23">23</a>–<a href="#ref-27">27</a></sup>. To note, modeling studies suggest that at least half of the overall benefits of these vaccines rest on indirect, rather than direct, protection<sup><a href="#ref-28">28</a></sup>. In other words, herd immunity is not an incidental bonus feature of these vaccines; it is why they are so effective.</p><p class="" id=d9873e368>Obviously, <i>B. pertussis</i> disease differs substantially from disease caused by HiB, pneumococcus, or meningococcus, whose pathogenesis is mediated by inflammation and/or the interaction between the pathogen and biological systems within the host (e.g. complement and coagulation cascades and inflammatory pathways). By contrast, pertussis deals death at a distance through the elaboration of multiple toxins whose contributions to the pathogenesis of classical pertussis disease are complex and remain only partially understood<sup><a href="#ref-29">29</a>–<a href="#ref-31">31</a></sup>. Nonetheless, it is reasonable to postulate that pertussis' ability to adhere to, infect, and persist on the human respiratory mucosa could be an important factor in the overall epidemiology of pertussis. This theory seems supported by recent experimental mouse model data showing that <i>B. pertussis</i> can form biofilms that allow it to adhere to abiotic surfaces as well as to murine nasal and tracheal mucosa<sup><a href="#ref-32">32</a></sup>. Several cross-sectional studies in humans have also presented data compatible with the hypothesis of asymptomatic infection. But, while suggestive, these are not definitive proof for the simple fact that pertussis, as with all infectious diseases, has an incubation period. Without longitudinal follow up, there is no way to know whether an asymptomatic infected individual sampled “today” was not destined to have become symptomatic in coming days<sup><a href="#ref-33">33</a>,<a href="#ref-34">34</a></sup>.</p></div><div class=section><a name=d9873e396 class=n-a></a><h3 class=section-title>Failure of traditional explanations to account for the resurgence of pertussis</h3><p class="" id=d9873e401>Compared to the pre-vaccine era, wP vaccines exerted a profound (~99%) reduction in pertussis incidence (<a href="#f1">Figure 1</a>)<sup><a href="#ref-35">35</a></sup>. But the newer-generation aP vaccines have been disappointing given that pertussis incidence has increased in many of the countries (though not all) where they replaced wP vaccines, including the US, Canada, Australia, Spain, Ireland, and the United Kingdom<sup><a href="#ref-36">36</a>–<a href="#ref-40">40</a></sup>. The key question is why.</p><p class="" id=d9873e418>Several hypotheses have been raised, of which the first three can be discounted:</p><p class="" id=d9873e421> <span style="text-decoration: underline">1.</span>&nbsp;&nbsp;<b>Detection bias:</b> traditional culture-based methods for diagnosing <i>B. pertussis</i> are insensitive because of the fastidious nature of the organism and because exposure to antibiotics can yield false negative results<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>. Such limitations could be overcome by using serologic markers of pertussis infection (such as a rise in anti-pertussis toxin [PTx] antibodies) or through the use of PCR, which may remain positive for weeks after the start of effective antibiotic therapy<sup><a href="#ref-43">43</a></sup>. The argument that PCR could result in an artefactual increase in incidence is intuitively appealing and could also explain the increased detection of milder/atypical presentations of pertussis<sup><a href="#ref-44">44</a>,<a href="#ref-45">45</a></sup>. Serologic markers are more difficult to interpret, since rises in titer may result from boosting after natural exposure absent disease or exposure to cross-reacting antigens.</p><p class="" id=d9873e452>Regardless, improved ascertainment does not adequately explain the increases in severe pertussis and deaths reported among infants. It has been argued that severe or fatal disease in young infants should be relatively robust against detection bias, being inherently unlikely to evade diagnosis and reporting. Furthermore, the timing of the rising incidence is difficult to reconcile. For example, in the US, infant pertussis rates had been slowly increasing since the 1970s, preceding the switch to enhanced diagnostics<sup><a href="#ref-11">11</a></sup>. Conversely, the UK’s Health Protection Agency shifted to PCR and serologic diagnostics in 2006 (<a href="#f3">Figure 3</a>)<sup><a href="#ref-46">46</a>,<a href="#ref-47">47</a></sup>. In the years 2007–2009, the total number of cases reported increased modestly from ~100–300/year to 600–800/year, coincident and possibly explained by the phase in enhanced diagnostics. But that pattern shifted abruptly in 2011–2012 with over 1,000 and 9,000 cases in each year, respectively. The degree and rapidity of that increase is not readily explained by a phased adoption of new diagnostic techniques. Rather, it is more suggestive of a multi-year nationwide outbreak of pertussis that peaked in 2012. Enhanced diagnostics, and particularly PCR, may explain some increase in detection and very likely explains some of the shift towards the detection of milder cases, but the increase in pertussis incidence is real, not artefactual.</p><div class="fig panel clearfix"><a name=f3 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/12588/41c45eee-9f54-43a4-9514-2a22b8b7190c_figure3.gif"><img alt="41c45eee-9f54-43a4-9514-2a22b8b7190c_figure3.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/12588/41c45eee-9f54-43a4-9514-2a22b8b7190c_figure3.gif"></a><div class=caption><h3>Figure 3. Pertussis incidence in the United Kingdom, by age group, 1998–2015.</h3><p id=d9873e480>This figure presents data from the United Kingdom of pertussis incidence disaggregated by age categories over a 17-year period. The introduction of enhanced pertussis diagnostics and of the transition from whole cell to acellular (aP) pertussis vaccines are noted in annotations. To note, the scale representing incidence differs by age category (≥6 months versus &lt;6 months of age). While there is year to year fluctuation in the incidence of pertussis, during the period 2011–2013, incidence rates spike. This abrupt increase cannot be easily explained as an artefact of enhanced diagnostics that were being phased in since 2006. A more parsimonious explanation is that this represents a nationwide epidemic of pertussis occurring after some delay from the transition to aP vaccines in 2005. PCR, polymerase chain reaction.</p></div></div><p class="" id=d9873e487><span style="text-decoration: underline">2.</span>&nbsp;&nbsp;&nbsp;<b>Poor vaccine coverage</b>: aP vaccines were first introduced in the US in 1991 at limited scale for the fourth or fifth doses of an otherwise wP vaccine series, switching to the fully aP series in 1996. According to 2015 state by state statistics from the CDC, among US toddlers aged 19–35 months between 91 and 99% received three or more doses of DTaP and between 76 and 92% had received four or more doses<sup><a href="#ref-48">48</a></sup>; the introduction of the Tdap boosters to adolescents, older adults, and most recently pregnant women has further expanded coverage<sup><a href="#ref-49">49</a></sup>. The rise in pertussis in the US occurred despite historically high uptake of pertussis vaccines.</p><p class="" id=d9873e503><span style="text-decoration: underline">3.</span>&nbsp;&nbsp;&nbsp;<b>Vaccine refusals:</b> as with measles, outbreaks of pertussis in unvaccinated or under-vaccinated populations have been well documented<sup><a href="#ref-50">50</a></sup>. Moreover, pertussis incidence increased among communities with high vaccine refusal rates, even among those who had been fully vaccinated, suggesting that the unvaccinated/under-vaccinated individuals pose a risk to the fully vaccinated members of those communities<sup><a href="#ref-51">51</a></sup>. Yet, given that US pertussis vaccine uptake is so high on average, the impact of vaccine-refusing communities must, by definition, be small and largely limited to those communities. It is difficult to see how this could significantly affect the overall increases seen across the general population in the US. Under-vaccination is an important factor in localized outbreaks but is insufficient to explain pertussis’ general and dispersed resurgence.</p><p class="" id=d9873e519>Evidence for two other hypotheses for the pertussis resurgence are more plausible:</p><p class="" id=d9873e522><span style="text-decoration: underline">4.</span>&nbsp;&nbsp;&nbsp;<b>Poor persistence of anti-pertussis antibodies following aP vaccination</b>: many studies have documented rapid declines in pertussis antibodies, often to baseline concentrations, within as few as 2–3 years of the last aP vaccination (DTaP or Tdap), and these declines coincide with falling clinical efficacy<sup><a href="#ref-52">52</a>–<a href="#ref-56">56</a></sup>. Klein <i>et al</i>. estimated a 42% increase in the odds of acquiring clinical pertussis disease per year since the fifth dose of DTaP<sup><a href="#ref-57">57</a></sup>. Similarly, a meta-analysis by McGirr and Fisman estimated that the odds of pertussis disease increased by 33% for each year after the last aP vaccination, such that only 10% of fully vaccinated infants would remain protected after a median of 8.5 years<sup><a href="#ref-58">58</a></sup>.</p><p class="" id=d9873e548>Such data argue that poor immunologic persistence is an important factor in the resurgence of pertussis. However, it seems unlikely that all of this can be explained by that factor. Logically, with waning immunity, one would expect to see the rise proportional to increasing age groups, with the rise highest in adolescents, lower in school-aged children and toddlers, and lowest of all among vaccinated infants, which is what the UK data show (<a href="#f3">Figure 3</a>)<sup><a href="#ref-46">46</a>,<a href="#ref-47">47</a></sup>. The increases are bimodal, with the largest increases in incidence occurring among individuals aged 10 years and over and among infants aged &lt;3 months. The rise among adolescents is well explained by poor immunological persistence after vaccination. By contrast, the increased incidence among infants too young to have been vaccinated is better explained by an overall rise in pertussis transmission, which may emanate from those older age groups. Immunologic persistence of protection elicited by aP vaccines has proven poorer than anticipated and very likely contributes to the resurgence of pertussis among older age groups. It is also likely that these older children act as a reservoir of infection that contributes to pertussis disease among very young infants.</p><p class="" id=d9873e562><span style="text-decoration: underline">5.</span>&nbsp;&nbsp;&nbsp;<b>Leaky efficacy due to evolutionary shifts</b>: in contrast to wP vaccines, which expose the human immune system to a wide complement of <i>B. pertussis</i> antigens, aP vaccines include only a few or even one (i.e. pertussis toxoid-only vaccines) highly standardized antigen/s. While far less reactogenic, a potential tradeoff is that the vaccine is less adaptable to the plasticity of the <i>B. pertussis</i> genome.</p><p class="" id=d9873e576>Bart and colleagues recently published a series of phylogenetic analyses among global pertussis isolates collected spanning the pre-vaccine era, the wP vaccine era, and the aP vaccine era<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>. The introduction of aP vaccines, and to a lesser degree wP vaccines, appeared to coincide with shifts away from the specific allelic isoforms of the genes coding for most of the aP vaccine antigens. This included Fim2 and Fim3, PRN, and PTx. In each case, there was a shift to allelic isoforms genetically distinct from those contained in the aP vaccine (e.g. <b>Fim 3-1</b> to Fim 3-2 and 3-3; <b>PRN1</b> to PRN2; and <b>PTxA2</b> to PTxA1 [the aP vaccine alleles are shown in <b>bold font</b>]). In addition, the predominant promoter gene for PTx shifted from <i>PtxP1</i> to <i>PtxP3</i>, notable because PTxP3 hyper-expresses PTx relative to PTxP1, a further strategy for immune evasion simply by increasing the concentration of the antigenic target. Lastly, multiple studies have identified disease-causing pertussis isolates that ceased expressing one or more of the aP antigen genes entirely, a definitive strategy for evading antibodies targeting these proteins. This includes, singly or in combination, PRN, FHA, and, more recently, PTx<sup><a href="#ref-61">61</a>–<a href="#ref-64">64</a></sup>. Strains expressing PRN have virtually disappeared from the US<sup><a href="#ref-65">65</a>,<a href="#ref-66">66</a></sup>. While rare and dissociated from the profound lymphocytosis often seen in infant pertussis and mediated by PTx specifically<sup><a href="#ref-61">61</a></sup>, PTx-minus strains are surprising given prior assumptions that PTx was an obligatory virulence factor<sup><a href="#ref-67">67</a></sup>.</p><p class="" id=d9873e627>But, while provocative, the degree to which these shifts contributed to the pertussis resurgence is unclear. This uncertainty is justified by the continued effectiveness of aP vaccines in a number of countries where non-vaccine alleles have become quite common. For example, Sweden’s pertussis toxoid-only vaccine has retained efficacy for over 20 years<sup><a href="#ref-68">68</a>,<a href="#ref-69">69</a></sup>. It is also true that pertussis rates were slowly trending up in the US since the 1970s preceding the switch from wP to aP vaccines, though this has accelerated dramatically in the aP vaccine era (<a href="#f1">Figure 1</a>).</p><p class="" id=d9873e640>Another problem with this explanation is that the rise in population incidence observed in multiple countries seems to occur roughly 5–10 years after switching to aP vaccines and that the increases in incidence are often quite abrupt (see <a href="#f2">Figure 2</a>). Presumably, the accumulation of non-vaccine antigen alleles among circulating strains of <i>B. pertussis</i> would be a gradual process, resulting in an incremental loss of efficacy with time. These abrupt step-wise transitions conflict with that expectation and do not account for why these seem to occur after a stereotypical delay from the wP to aP switch.</p><p class="" id=d9873e649>A good example of this leverages the natural experiment afforded by the US’ switch from wP to aP vaccines between 1991 and 1996. Klein <i>et al</i>. examined the incidence of PCR-confirmed pertussis illnesses as a function of age, which provided the natural experiment: anyone under the age of 11 years would mainly have received aP vaccines, those over the age of 15 could have received only wP vaccines, and those in between would have received a blended schedule of wP and aP vaccines. As shown in <a href="#f4">Figure 4</a>, the incidence of pertussis increased with advancing age through 10 years, a trend well explained by waning immunity. But then incidence drops precipitously among the older cohorts who had received partly or fully wP vaccine schedules as infants, falling nearly to zero incidence among those 15 years and older. These data argue that wP vaccines were far more effective than aP vaccines (overall far lower incidence) and that they induced protective efficacy for significantly longer (i.e. beyond 15 years). Such striking differences also raise the following question: do the two classes of vaccine work immunologically in the same ways? We will return to this issue subsequently. Evolutionary shifts are likely in response to aP vaccines (and to a lesser degree wP vaccines) and plausibly contribute to the pertussis resurgence by degrading the efficacy of certain aP vaccines. But the extent of contribution is uncertain, and the abrupt rises in incidence do not fit well with evolution as the driving factor.</p><div class="fig panel clearfix"><a name=f4 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/12588/41c45eee-9f54-43a4-9514-2a22b8b7190c_figure4.gif"><img alt="41c45eee-9f54-43a4-9514-2a22b8b7190c_figure4.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/12588/41c45eee-9f54-43a4-9514-2a22b8b7190c_figure4.gif"></a><div class=caption><h3>Figure 4. A natural experiment exploring the effect of infant exposure to acellular or whole cell pertussis vaccines and age-specific incidence of pertussis</h3><p id=d9873e668>These data from the Kaiser Permanente health maintenance organization in Northern California reflect a natural experiment centered on the transition from whole cell to acellular pertussis vaccines in the US in the 1990s. These data were all collected over a narrow time window, and so the incidence by age should be understood in relation to what vaccine these individuals had received as infants. Those above the age of 15 could have received only whole cell pertussis vaccines, those under the age of 11 could have received only acellular pertussis vaccines, and those aged in between could have received a blended schedule of both vaccines, reflecting the transition period. The blue line depicts pertussis incidence as a function of age; the red line represents the proportion of each age stratum that received the acellular vaccine (100% of those vaccinated below the age of 11; ~0% of those aged 15 years and older). We make several observations: First, there is a decline in incidence from birth through the first year of life. This is likely explained by the induction of immunity through infant vaccination. Pertussis incidence then increases steadily through age 10. In light of what has been learned, this most likely reflects waning of acellular pertussis vaccine-induced immunity with time. Second, rather than continuing to rise with age, the incidence instead plummets above the age of 11 years, falling essentially to zero in those 15 years and older. It is remarkable to observe that receipt of any whole cell pertussis vaccines during infancy continues to exert such durable protection, to the extent that the 15 years and older birth cohort remain almost completely protected even decades out. This strongly argues that the immunologic effects resulting from whole cell and acellular pertussis vaccines are quite distinct. DTaP, diphtheria, tetanus, and acellular pertussis.</p></div></div></div><div class=section><a name=d9873e676 class=n-a></a><h3 class=section-title>Novel insights into pertussis transmission from modeling studies</h3><p class="" id=d9873e681>In summary, persistence and evolutionary shifts likely contribute to the pertussis resurgence but seem insufficient to explain current disease trends. Something is still missing.</p><p class="" id=d9873e684>It has been argued that wP vaccines prevent disease but do not block infections. This conclusion rests on a single influential study published by Fine and Clarkson in the Lancet in 1982<sup><a href="#ref-70">70</a></sup>. Their core argument concerned changes in the time period between pertussis epidemics and whether these expanded during the wP vaccine era (evidence that transmission was being impeded) (see examples in <a href="#f5">Figure 5</a>). They found some lengthening of the inter-epidemic period but deemed this insufficient to suggest a decline in transmission and so concluded that wP vaccines did not prevent infections.</p><div class="fig panel clearfix"><a name=f5 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/12588/41c45eee-9f54-43a4-9514-2a22b8b7190c_figure5.gif"><img alt="41c45eee-9f54-43a4-9514-2a22b8b7190c_figure5.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/12588/41c45eee-9f54-43a4-9514-2a22b8b7190c_figure5.gif"></a><div class=caption><h3>Figure 5. Effect of infection-blocking versus disease-preventing vaccines on the inter-epidemic cycle lengths of a hypothetical respiratory disease.</h3><p id=d9873e704>These cartoons depict the effect on inter-epidemic cycle lengths by vaccines with different immunological effects in terms of whether they prevent infections (regardless of symptoms) as well as clinical disease (by definition symptomatic) or that only prevent clinical disease. At a population level, immunity waxes and wanes over time. With increased infection rates, the population acquires immunity and disease incidence subsequently falls. Over time, population immunity wanes (for example, because of the introduction of non-immune infants born into the population), leading to a resurgence of disease. The inter-epidemic cycle length is the average time between peaks in this cycle. The amplitude of each peak reflects the number of observed symptomatic cases in the population.</p><p id=d9873e707>&nbsp;&nbsp;•&nbsp;&nbsp;Panel A depicts the base case absent any vaccination. For pertussis absent vaccination, the inter-epidemic cycle length has been estimated at between 3 and 5 years.</p><p id=d9873e710>&nbsp;&nbsp;•&nbsp;&nbsp;Panel B depicts the effect of a vaccine that prevents infections and clinical disease. By blocking infections, the pace of spread through the population is slowed, leading to an extension of the inter-epidemic cycle length as well as a decline in amplitude of peaks due to prevention of clinical disease.</p><p id=d9873e713>&nbsp;&nbsp;•&nbsp;&nbsp;Panel C depicts a vaccine that fails to block infection but effectively prevents clinical disease. This vaccine only reduces the amplitude of peaks but has no impact on period length, since transmission is not affected.</p></div></div><p class="" id=d9873e720>This conclusion is oft-cited and well engrained in the literature and official texts<sup><a href="#ref-71">71</a>,<a href="#ref-72">72</a></sup> but is arguably flawed. Co-author Rohani and his team re-examined period lengths across multiple cities in England and Wales before and after wP vaccine introduction, with each city serving as its own control<sup><a href="#ref-73">73</a></sup>. When the data were aligned in this way, lengthening of inter-epidemic periods became more apparent, with average increases in each city of 1.5–2.5 years. This observation has since been replicated in 64 countries<sup><a href="#ref-10">10</a>,<a href="#ref-74">74</a>,<a href="#ref-75">75</a></sup>. In our view, the preponderance of evidence argues that wP vaccines impede disease transmission as well as prevent clinical disease<sup><a href="#ref-76">76</a></sup>.</p><p class="" id=d9873e749>This issue was readdressed by the modelers Althouse and Scarpino but now studying the question in reverse by focusing on the transition from wP to aP vaccines<sup><a href="#ref-12">12</a></sup>. Using a signal-processing technique called “wavelet analysis”, they found that the switch to aP vaccines preceded a contraction of the inter-epidemic period length, the opposite of introducing wP vaccines to a vaccine-naïve population.</p><p class="" id=d9873e756>The Althouse/Scarpino model further combined population-level incidence data and phylogenetic data mapping the genetic evolution of <i>B. pertussis</i> as a means to account for the burden of disease through observed contact linkages over space and time. Their surprising finding was a far higher pace of genetic mutation than could be accounted for via visible transmission pathways between known symptomatic cases. This excess genetic diversity implies longer chains of transmission between observed cases and therefore argues for the existence of asymptomatic transmission routes. This conclusion echoes that of the British epidemiologists Miller and Gay, writing in 2000, 4 years before the introduction of aP vaccines into the infant schedule<sup><a href="#ref-77">77</a></sup>. Disease among infants &lt;3 months old (i.e. too young to have been vaccinated) increased sharply in the late 1970s, coincident with declines in wP coverage rates. As wP coverage improved in the 1980s, pertussis incidence fell, including among young infants. Surprisingly, though, the infant rates stabilized in the 100–200 cases/100,000 infants/year range, even as disease among older age groups fell almost to zero. Since those infants are unlikely to be their own reservoir for infection, a more plausible explanation was transmission from a sustained pool of asymptomatic older individuals in the population<sup><a href="#ref-77">77</a></sup>. This also emphasizes that even very high rates of wP vaccination may fail to completely interrupt pertussis transmission.</p><p class="" id=d9873e770>These models also offer a possible explanation for the surprising failure of “cocooning” to protect infants from pertussis. Cocooning refers to the strategy of administering Tdap to all household contacts (particularly the mother) of a newborn to prevent spread to the infant during the early months of life. Cocooning is logical but presupposes that aP vaccines prevent asymptomatic infections. Unfortunately, several controlled trials of cocooning in the US found no efficacy<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a>,<a href="#ref-78">78</a></sup>. These counterintuitive results conflict with expectations if aP vaccines block carriage and transmission but fit well if aP vaccines only prevent disease but have more limited ability to block infections.</p></div><div class=section><a name=d9873e784 class=n-a></a><h3 class=section-title>Recent experimental animal data show differential effects of aP and wP vaccines</h3><p class="" id=d9873e789>Perhaps the most direct evidence of asymptomatic carriage and its implications emerged from an elegant series of experiments by Warfel and Merkel at the FDA using a newly developed infant baboon model. The key experiments in this series involved groups of infant baboons who were unvaccinated, vaccinated with aP vaccines, or vaccinated with wP vaccines and subsequently infected via exposure to aerosols of <i>B. pertussis</i><sup><a href="#ref-79">79</a></sup>. In each case, vaccine-naïve baboons developed clinical illness, whereas aP- or wP-vaccinated animals remained asymptomatic (no coughing or lymphocytosis).</p><p class="" id=d9873e798>However, the animals also underwent serial NP sampling over the ensuing days and weeks, and here clear differences between the aP- and wP-vaccinated animals emerged. Among the wP-vaccinated baboons, NP carriage was detectable for a mean of 18 days (at low carriage densities) versus 30 and 35 days (at high densities) for naïve and aP-vaccinated animals, respectively. In fact, aP-vaccinated baboons eradicated NP colonization no more quickly than unvaccinated animals.</p><p class="" id=d9873e801>Follow-on experiments shed further light. Infant baboons immunized with aP vaccines and then infected with <i>B. pertussis</i> (but asymptomatic) were co-housed with vaccine-naïve baboons who had not been exposed to the <i>B. pertussis</i> aerosols: the unvaccinated cage mate animals also became infected, showing that aP-vaccinated animals remained contagious.</p><p class="" id=d9873e810>Approaching this in the opposite direction, the investigators infected a vaccine-naïve animal with pertussis and then co-housed it with both an aP-vaccinated animal and a second vaccine-naïve animal<sup><a href="#ref-80">80</a></sup>. Both of these animals acquired NP carriage at the same colonization density.</p><p class="" id=d9873e818>In a final experiment, female baboons were vaccinated with aP vaccines during pregnancy. Post-partum, the infant baboons were exposed to pertussis aerosols but were fully protected from clinical disease. However, all became colonized at similar densities as the infant baboons of unvaccinated mothers<sup><a href="#ref-81">81</a></sup>.</p><p class="" id=d9873e825>In summary, these animal experiments demonstrate that aP vaccines prevent disease but not infection and that this clinical protection is mediated by antibody, is transferable over the placenta, and can prevent disease post-partum in infants. But the aP vaccine-derived antibodies do not block colonization of the nasopharynx, allowing aP-vaccinated and passively protected animals to become infected and to propagate transmission. By contrast, wP-vaccinated animals diminished carriage in both bacterial burden and duration, clearing infections in half the time required by vaccine-naïve or aP-vaccinated animals. To further quantify this, they compared the cumulative area under the curve for <i>B. pertussis</i> shedding from the nasopharynx of vaccinated and infected animals: wP vaccines reduced the total burden of bacterial shedding by &gt;1,000-fold compared with DTaP<sup><a href="#ref-82">82</a></sup>.</p><p class="" id=d9873e835>Empiric human evidence from a recent longitudinal study supports these interpretations. Looking at secondary attack rates among vaccine failures, the investigators calculated that wP vaccination reduced secondary infections by 86% compared with only 6% from aP vaccines<sup><a href="#ref-83">83</a></sup>.</p></div><div class=section><a name=d9873e844 class=n-a></a><h3 class=section-title>Recent immunologic insights and a possible missing link</h3><p class="" id=d9873e849>As suggested by Klein’s natural experiment data (<a href="#f4">Figure 4</a>), the effects of wP and aP vaccines appear distinct. But what immunologic mechanism mediates these differences?</p><p class="" id=d9873e855>For decades, it was understood that naïve T-helper cells can differentiate into distinct lineages with distinct phenotypes and functional roles based on exposure to different combinations of antigenic stimuli, cytokine-mediated extracellular signaling from antigen presenting cells (APCs), and the specific combination of co-receptor molecules present at the interface between T-cells and the APC. The net result of these forces induces T-helper cells to adopt one of two functional phenotypes: TH1 or TH2<sup><a href="#ref-84">84</a></sup>. TH1 cells are optimized for cell-mediated immunity targeting intracellular pathogens (such as tuberculosis), with actions mediated indirectly by T8 effector cells. By contrast, TH2 cells are optimized to stimulate B-cells for extracellular killing mediated primarily via antibodies and play a central role in allergic responses and controlling parasitic helminth infections. Yet, while helpful, this model has evident gaps, since it does not clearly explain a number of opportunistic conditions that characterize HIV/AIDS but lack a clear link to either TH1 or TH2 phenotypes.</p><p class="" id=d9873e862>More recently, a third TH cell developmental pathway was identified, whose inclusion seems to fill many of the gaps left by the TH1/TH2 paradigm. This was named TH17 in reference to the dominant cytokine (interleukin 17) released by APCs. TH17 lymphocytes direct neutrophil-mediated extracellular immune responses on mucosal surfaces, and deficits in TH17 manifest clinically as an inability to eradicate mucosal carriage and increased susceptibility to pathogens that colonize mucosal surfaces<sup><a href="#ref-85">85</a></sup>. Since HIV degrades TH17 and TH1 responses, whereas TH2 responses may actually increase in the setting of HIV/AIDS, this provides a far more satisfying explanation for such HIV-associated conditions as <i>Candida albicans</i> esophagitis, <i>Pneumocystis jirovecii</i> pneumonia, <i>Cryptococcus neoformans</i> meningitis, and invasive pneumococcal disease, conditions strongly associated with pathogen proliferation upon, and invasion across, mucosal surfaces. TH17 also proves directly relevant to pertussis<sup><a href="#ref-86">86</a>,<a href="#ref-87">87</a></sup>.</p><p class="" id=d9873e885>Warfel and Merkel assayed T-cell phenotypes in their infant baboons before and after infection with <i>B. pertussis</i>, or wP or aP vaccination. Pertussis infection triggered a purely TH17 response, whereas wP vaccination led to a predominantly TH17 response, with a lesser TH1 response. By contrast, aP vaccines induced only TH2 responses, which resulted in (mostly IgE) antibody generation and would not be expected to interfere with pathogens on mucosal surfaces<sup><a href="#ref-88">88</a></sup>.</p><p class="" id=d9873e896>These data suggest a definable immunologic mechanism distinguishing wP and aP vaccines that explains their differential effects on mucosal immunity and herd immunity and go a long way towards harmonizing the experimental and modeling data.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d9873e903>Reconciling the exceptions</h2><p class="" id=d9873e906>It must be acknowledged that the resurgence of pertussis seen in the US, the UK, and elsewhere has not occurred universally. Indeed, a recent analysis shows considerable heterogeneity in disease incidence among 20 countries that switched from wP to aP vaccinations<sup><a href="#ref-76">76</a></sup>. This emphasizes the complexity of the issue and the multiplicity of relevant factors that could influence incidence rates beyond a simple difference in vaccines: differential vaccine histories, pre-existing levels of herd immunity, birth rates, vaccine schedules, the specific make and composition of vaccines being employed, surveillance techniques, and the quality of data on which these estimates rest.</p><p class="" id=d9873e913>With that said, three countries merit particular mention because they are so often cited as counterfactual examples of the consequences of switching to aP vaccines. These are Japan (the first country to adopt aP vaccines globally), Italy, and Sweden.</p><p class="" id=d9873e916>The circumstances surrounding each of these examples is quite different from the US/UK/Canada/Spain/Australia contexts, where wP vaccines were phased out and aP vaccines phased in without interruption over a short period of transition (i.e. 1–2 years). To start with, Japan ceased using wP vaccines in 1974 following several deaths among wP-vaccinated infants. After a 7-year gap with no pertussis vaccines being used, Japan resumed using an aP vaccine in 1981<sup><a href="#ref-89">89</a></sup>. Similarly, Sweden ceased all pertussis vaccinations in 1979, resuming with a monovalent aP vaccine after a 17-year hiatus in 1996<sup><a href="#ref-90">90</a></sup>. In both cases, it is reasonable to assume that these gaps in coverage resulted in some loss of herd immunity achieved during the period of wP vaccine use, which makes it hard to draw meaningful comparisons about the shift from wP to aP vaccines. By contrast, in Italy, wP vaccines were in continuous use since the 1960s, but vaccine coverage was very poor (&lt;40%). In response to rising incidence in the 1980s, aP vaccines were introduced in 1994 while simultaneously achieving very high rates (&gt;90%) of vaccine coverage. But, while the pertussis burden fell sharply in the ‘90s, it is impossible to know whether incidence fell because of the change in vaccine or because of the increase in coverage<sup><a href="#ref-91">91</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d9873e934>A hypothesis: a second pathway to herd immunity?</h2><p class="" id=d9873e937>While the experimental and immunologic data suggest that aP vaccines fail to induce sterilizing mucosal immunity, the modeling data imply that aP vaccines probably do provide some degree of herd immunity. Co-author Rohani notes that mathematical models that include no impact on disease transmission cannot explain the observed epidemiologic data<sup><a href="#ref-92">92</a></sup>. For example, the monovalent PTx-only aP vaccine in Sweden led to impressive reductions in pertussis incidence outside of vaccinated populations, a signature of herd effect<sup><a href="#ref-93">93</a>,<a href="#ref-94">94</a></sup>.</p><p class="" id=d9873e951>But if the baboon data apply to humans and mucosal immunity is weak or absent following aP vaccines, how do we reconcile this apparent contradiction? Can we postulate another pathway to herd protection?</p><p class="" id=d9873e954>Several observations and some biologically plausible inferences may provide a clue. Warfel also showed that aerosol transmission occurred in the infant baboon model among animals housed in cages several meters away from an infected animal<sup><a href="#ref-95">95</a></sup>. This confirms that both short-range and long-range transmission of pertussis may occur. An undisputed benefit of aP vaccines is to prevent clinical disease, meaning that individuals do not suffer paroxysmal coughs. It is no great leap of faith to see paroxysmal coughing as a highly efficient way of generating infectious aerosols and enhancing long-distance transmission without requiring the kind of intimate close-contact between co-housed baboons – or that exists between a human mother and her baby. If so, aP vaccines would render infected individuals less contagious, even if they do not induce resistance to infection among those who were exposed. In this model, herd immunity reflects changes in the phenotype of disease expression reducing contagiousness (mediated by TH2 responses generating antibodies against PTx and other factors) rather than shifts in mucosal immunity (via TH17 responses) conferring resistance to exposure. This is a testable hypothesis.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d9873e964>A proposed synthesis</h2><p class="" id=d9873e967>We summarize the following key points in our discussion: 1) wP vaccinations curtailed pertussis disease and transmission; 2) pertussis rates increased with the introduction of aP vaccines in many (but not all) countries where there was a direct transition from wP to aP vaccinations; 3) modeling suggests that herd immunity is weaker for aP than wP vaccines; 4) the current burden of disease is not well explained by the disease that is observed but implies asymptomatic chains of transmission; 5) aP vaccination, or passively acquired antibodies resulting from aP vaccination, prevents symptomatic disease in animals but does not block infections; 6) transmission readily occurs between asymptomatic aP-vaccinated but infected animals to uninfected animals in close physical proximity; 7) wP and aP vaccines induce very different immunological responses in animals; 8) there are definable T-cell-mediated pathways (TH17) that confer mucosal immunity; 9) TH17 responses are robust following natural infection and wP vaccination but absent following aP vaccination, which only induces TH2 responses; and 10) the presence of TH17 responses aligns with a reduction in NP carriage in infant baboons.</p><p class="" id=d9873e970>In conclusion, the preponderance of available evidence now suggests that the list of plausible explanations for the resurgence of pertussis in the aP vaccination era goes beyond the “poor persistence” and “waning efficacy” of these vaccines to include an additional and likely pivotal factor: “lack of sterilizing mucosal immunity”. What is missing is direct evidence to validate this chain of logic, to go beyond the limitations of animal models, and to provide human data to support the hypotheses raised by the epidemiologists, experimentalists, and modelers. This issue would be greatly informed by carriage studies of <i>B. pertussis</i> among the general population, particularly around transitions in vaccine policy (such as future wP to aP transitions), and as an endpoint in clinical trials of any new third-generation pertussis vaccines.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d9873e980>Where do we go now?</h2><p class="" id=d9873e983>Fundamental aspects of pertussis epidemiology and immunology were left unexplained following the introduction of wP vaccines in the 1950s. The wP vaccines worked: disease rates plummeted, mortality fell, and the pertussis problem appeared largely solved. The fact that we did not know then, and still do not know now, how wP vaccines did this was inconvenient and has remained problematic in the aP vaccine era, since it created no clear immunologic surrogate by which to bridge these vaccine classes. Had carriage studies been conducted in parallel with wP introductions, then this might have provided supportive evidence that infections were being blocked. But carriage studies were not done. Rather, it was assumed that because wP vaccines appeared to confer herd immunity, they therefore blocked carriage. In hindsight and in light of subsequent evidence, that assumption was probably correct. It was subsequently assumed that aP vaccines, most of which include combinations of adhesion protein antigens (PRN, FHA, Fim2/3) that enable <i>B. pertussis</i> to bind to respiratory epithelium, would also block carriage. But, while logical, that assumption appears to have been incorrect.</p><p class="" id=d9873e989>In our view, we are approaching a critical decision point. In the US, pertussis rates and infant pertussis deaths are now at a 70-year high, and despite record uptake of aP vaccines, pertussis rates in the US have continued to rise, casting doubt on whether further increasing aP vaccine coverage can ever compensate for their fundamental limitations. Stanley Plotkin, among others, has offered several possible approaches to deal with this situation: (i) a return to the reactogenic wP vaccines (which would be challenging given our increasingly vaccine-averse population); (ii) integration of wP and aP vaccines in the infant schedules (also a difficult “sell”, notwithstanding that there are no longer any wP vaccines licensed in the US); (iii) attempts to broaden and enhance the immunogenicity of aP vaccines by adding in lipopolysaccharide or novel adjuvants; or (iv) developing new pertussis vaccines, including live-attenuated nasal vaccines that could be delivered directly at the NP mucosa specifically to enhance mucosal immunity<sup><a href="#ref-96">96</a>–<a href="#ref-99">99</a></sup>.</p><p class="" id=d9873e999>It is too early to predict how this will play out, but it seems essential that any future pertussis vaccine demonstrates its ability not just to prevent clinical disease but also to prevent infections, and showing this to be so will require carriage studies. The resurgence of pertussis in the aP vaccine era is evolving into a slow-moving global public health crisis. But, with the public’s trust in vaccines waning, this has also become a public relations crisis<sup><a href="#ref-100">100</a></sup>.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d9873e1 class=n-a></a><h2 class=main-title id=d10157>Competing interests</h2><p class=metadata-entry><a name=d9873e126 class=n-a></a><p id=d9873e128> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d9873e1 class=n-a></a><h2 class=main-title id=d10159>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d9873e1010 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d10475>References</h2><div class="section ref-list"><a name=d9873e1010 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d9873e1017 class=n-a></a>Robbins JB, Schneerson R, Trollfors B: Pertussis in developed countries. <i>Lancet.</i> 2002; <b>360</b>(9334): 657–8. <a target=xrefwindow id=d9873e1025 href="http://www.ncbi.nlm.nih.gov/pubmed/12241870">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1028 href="http://dx.doi.org/10.1016/S0140-6736(02)09882-3">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d9873e1037 class=n-a></a>De Serres G, Duval B: Pertussis vaccination beyond childhood. <i>Lancet.</i> 2005; <b>365</b>(9464): 1015–6. <a target=xrefwindow id=d9873e1045 href="http://www.ncbi.nlm.nih.gov/pubmed/15781085">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1048 href="http://dx.doi.org/10.1016/S0140-6736(05)71121-1">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d9873e1057 class=n-a></a>Cutts FT, Fine PE: Caution--mortality ratios ahead. <i>Lancet.</i> 2003; <b>361</b>(9376): 2169–70. <a target=xrefwindow id=d9873e1065 href="http://www.ncbi.nlm.nih.gov/pubmed/12842364">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1068 href="http://dx.doi.org/10.1016/S0140-6736(03)13783-X">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d9873e1077 class=n-a></a>Edwards KM: Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. <i>Pediatr Infect Dis J.</i> 2005; <b>24</b>(6 Suppl): S104–8. <a target=xrefwindow id=d9873e1085 href="http://www.ncbi.nlm.nih.gov/pubmed/15931137">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1088 href="http://dx.doi.org/10.1097/01.inf.0000166154.47013.47">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d9873e1097 class=n-a></a>Roca A, Hill PC, Townend J, <i> et al.</i>: Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial. <i>PLoS Med.</i> 2011; <b>8</b>(10): e1001107. <a target=xrefwindow id=d9873e1108 href="http://www.ncbi.nlm.nih.gov/pubmed/22028630">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1111 href="http://dx.doi.org/10.1371/journal.pmed.1001107">Publisher Full Text </a> | <a target=xrefwindow id=d9873e1115 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3196470">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d9873e1125 class=n-a></a>Lipsitch M: Vaccination against colonizing bacteria with multiple serotypes. <i>Proc Natl Acad Sci U S A.</i> 1997; <b>94</b>(12): 6571–6. <a target=xrefwindow id=d9873e1133 href="http://www.ncbi.nlm.nih.gov/pubmed/9177259">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1136 href="http://dx.doi.org/10.1073/pnas.94.12.6571">Publisher Full Text </a> | <a target=xrefwindow id=d9873e1139 href="http://www.ncbi.nlm.nih.gov/pmc/articles/21091">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d9873e1148 class=n-a></a>Maiden MC, Stuart JM; UK Meningococcal Carraige Group: Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. <i>Lancet.</i> 2002; <b>359</b>(9320): 1829–31. <a target=xrefwindow id=d9873e1156 href="http://www.ncbi.nlm.nih.gov/pubmed/12044380">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1159 href="http://dx.doi.org/10.1016/S0140-6736(02)08679-8">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d9873e1168 class=n-a></a>Winter K, Glaser C, Watt J, <i> et al.</i>: Pertussis epidemic--California, 2014. <i>MMWR Morb Mortal Wkly Rep.</i> 2014; <b>63</b>(48): 1129–32. <a target=xrefwindow id=d9873e1179 href="http://www.ncbi.nlm.nih.gov/pubmed/25474033">PubMed Abstract </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d9873e1188 class=n-a></a>Centers for Disease Control and Prevention (CDC): Pertussis--United States, 2001–2003. <i>MMWR Morb Mortal Wkly Rep.</i> 2005; <b>54</b>(50): 1283–6. <a target=xrefwindow id=d9873e1196 href="http://www.ncbi.nlm.nih.gov/pubmed/16371944">PubMed Abstract </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d9873e1205 class=n-a></a>Broutin H, Viboud C, Grenfell BT, <i> et al.</i>: Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries. <i>Proc Biol Sci.</i> 2010; <b>277</b>(1698): 3239–45. <a target=xrefwindow id=d9873e1216 href="http://www.ncbi.nlm.nih.gov/pubmed/20534609">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1219 href="http://dx.doi.org/10.1098/rspb.2010.0994">Publisher Full Text </a> | <a target=xrefwindow id=d9873e1223 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2981935">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d9873e1232 class=n-a></a>Rohani P, Drake JM: The decline and resurgence of pertussis in the US. <i>Epidemics.</i> 2011; <b>3</b>(3–4): 183–8. <a target=xrefwindow id=d9873e1240 href="http://www.ncbi.nlm.nih.gov/pubmed/22094341">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1243 href="http://dx.doi.org/10.1016/j.epidem.2011.10.001">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725585738"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9873e1253 class=n-a></a>Althouse BM, Scarpino SV: Asymptomatic transmission and the resurgence of <i>Bordetella pertussis</i>. <i>BMC Med.</i> 2015; <b>13</b>: 146. <a target=xrefwindow id=d9873e1264 href="http://www.ncbi.nlm.nih.gov/pubmed/26103968">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1267 href="http://dx.doi.org/10.1186/s12916-015-0382-8">Publisher Full Text </a> | <a target=xrefwindow id=d9873e1271 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4482312">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725585738">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d9873e1284 class=n-a></a>Stokley S, Cohn A, Dorell C, <i> et al.</i>: Adolescent vaccination-coverage levels in the United States: 2006–2009. <i>Pediatrics.</i> 2011; <b>128</b>(6): 1078–86. <a target=xrefwindow id=d9873e1295 href="http://www.ncbi.nlm.nih.gov/pubmed/22084326">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1298 href="http://dx.doi.org/10.1542/peds.2011-1048">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d9873e1307 class=n-a></a>Stokley S, Cohn A, Jain N, <i> et al.</i>: Compliance with recommendations and opportunities for vaccination at ages 11 to 12 years: evaluation of the 2009 national immunization survey-teen. <i>Arch Pediatr Adolesc Med.</i> 2011; <b>165</b>(9): 813–8. <a target=xrefwindow id=d9873e1318 href="http://www.ncbi.nlm.nih.gov/pubmed/21893647">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1321 href="http://dx.doi.org/10.1001/archpediatrics.2011.138">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718480198"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9873e1330 class=n-a></a>Healy CM, Rench MA, Wootton SH, <i> et al.</i>: Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. <i>Pediatr Infect Dis J.</i> 2015; <b>34</b>(1): 22–6. <a target=xrefwindow id=d9873e1341 href="http://www.ncbi.nlm.nih.gov/pubmed/24992123">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1344 href="http://dx.doi.org/10.1097/INF.0000000000000486">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718480198">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d9873e1357 class=n-a></a>Castagnini LA, Healy CM, Rench MA, <i> et al.</i>: Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. <i>Clin Infect Dis.</i> 2012; <b>54</b>(1): 78–84. <a target=xrefwindow id=d9873e1368 href="http://www.ncbi.nlm.nih.gov/pubmed/22075790">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1371 href="http://dx.doi.org/10.1093/cid/cir765">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d9873e1380 class=n-a></a>Moulton LH, Chung S, Croll J, <i> et al.</i>: Estimation of the indirect effect of <i>Haemophilus influenzae</i> type b conjugate vaccine in an American Indian population. <i>Int J Epidemiol.</i> 2000; <b>29</b>(4): 753–6. <a target=xrefwindow id=d9873e1394 href="http://www.ncbi.nlm.nih.gov/pubmed/10922355">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1398 href="http://dx.doi.org/10.1093/ije/29.4.753">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d9873e1408 class=n-a></a>Obaro S, Adegbola R: The pneumococcus: carriage, disease and conjugate vaccines. <i>J Med Microbiol.</i> 2002; <b>51</b>(2): 98–104. <a target=xrefwindow id=d9873e1416 href="http://www.ncbi.nlm.nih.gov/pubmed/11863272">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1419 href="http://dx.doi.org/10.1099/0022-1317-51-2-98">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d9873e1428 class=n-a></a>O'Brien KL, Dagan R: The potential indirect effect of conjugate pneumococcal vaccines. <i>Vaccine.</i> 2003; <b>21</b>(17–18): 1815–25. <a target=xrefwindow id=d9873e1436 href="http://www.ncbi.nlm.nih.gov/pubmed/12706665">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1439 href="http://dx.doi.org/10.1016/S0264-410X(02)00807-1">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d9873e1448 class=n-a></a>Trotter CL, Andrews NJ, Kaczmarski EB, <i> et al.</i>: Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. <i>Lancet.</i> 2004; <b>364</b>(9431): 365–7. <a target=xrefwindow id=d9873e1459 href="http://www.ncbi.nlm.nih.gov/pubmed/15276396">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1462 href="http://dx.doi.org/10.1016/S0140-6736(04)16725-1">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d9873e1471 class=n-a></a>Zhang Q, Finn A: Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria. <i>J Clin Pathol.</i> 2004; <b>57</b>(10): 1015–21. <a target=xrefwindow id=d9873e1479 href="http://www.ncbi.nlm.nih.gov/pubmed/15452151">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1482 href="http://dx.doi.org/10.1136/jcp.2004.016253">Publisher Full Text </a> | <a target=xrefwindow id=d9873e1485 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1770445">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d9873e1494 class=n-a></a>Trotter CL, Gay NJ, Edmunds WJ: Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. <i>Am J Epidemiol.</i> 2005; <b>162</b>(1): 89–100. <a target=xrefwindow id=d9873e1502 href="http://www.ncbi.nlm.nih.gov/pubmed/15961591">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1505 href="http://dx.doi.org/10.1093/aje/kwi160">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d9873e1514 class=n-a></a>Centers for Disease Control and Prevention (CDC): Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998–2003. <i>MMWR Morb Mortal Wkly Rep.</i> 2005; <b>54</b>(36): 893–7. <a target=xrefwindow id=d9873e1522 href="http://www.ncbi.nlm.nih.gov/pubmed/16163262">PubMed Abstract </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d9873e1532 class=n-a></a>O'Brien KL, Millar EV, Zell ER, <i> et al.</i>: Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. <i>J Infect Dis.</i> 2007; <b>196</b>(8): 1211–20. <a target=xrefwindow id=d9873e1543 href="http://www.ncbi.nlm.nih.gov/pubmed/17955440">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1546 href="http://dx.doi.org/10.1086/521833">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d9873e1555 class=n-a></a>Stephens DS: Uncloaking the meningococcus: dynamics of carriage and disease. <i>Lancet.</i> 1999; <b>353</b>(9157): 941–2. <a target=xrefwindow id=d9873e1563 href="http://www.ncbi.nlm.nih.gov/pubmed/10459897">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1566 href="http://dx.doi.org/10.1016/S0140-6736(98)00279-7">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d9873e1575 class=n-a></a>Zhang Q, Pettitt E, Burkinshaw R, <i> et al.</i>: Mucosal immune responses to meningococcal conjugate polysaccharide vaccines in infants. <i>Pediatr Infect Dis J.</i> 2002; <b>21</b>(3): 209–13. <a target=xrefwindow id=d9873e1586 href="http://www.ncbi.nlm.nih.gov/pubmed/12005084">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1589 href="http://dx.doi.org/10.1097/00006454-200203000-00010">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d9873e1598 class=n-a></a>Dagan R, Givon-Lavi N, Zamir O, <i> et al.</i>: Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant <i>Streptococcus pneumoniae</i> in day-care centers. <i>Pediatr Infect Dis J.</i> 2003; <b>22</b>(6): 532–40. <a target=xrefwindow id=d9873e1612 href="http://www.ncbi.nlm.nih.gov/pubmed/12799510">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1616 href="http://dx.doi.org/10.1097/01.inf.0000069761.11093.c3">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d9873e1625 class=n-a></a>Stephens DS: Protecting the herd: the remarkable effectiveness of the bacterial meningitis polysaccharide-protein conjugate vaccines in altering transmission dynamics. <i>Trans Am Clin Climatol Assoc.</i> 2011; <b>122</b>: 115–23. <a target=xrefwindow id=d9873e1633 href="http://www.ncbi.nlm.nih.gov/pubmed/21686214">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1636 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3116338">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d9873e1645 class=n-a></a>Hewlett EL, Burns DL, Cotter PA, <i> et al.</i>: Pertussis pathogenesis--what we know and what we don't know. <i>J Infect Dis.</i> 2014; <b>209</b>(7): 982–5. <a target=xrefwindow id=d9873e1656 href="http://www.ncbi.nlm.nih.gov/pubmed/24626533">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1659 href="http://dx.doi.org/10.1093/infdis/jit639">Publisher Full Text </a> | <a target=xrefwindow id=d9873e1663 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3952676">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d9873e1673 class=n-a></a>Mattoo S, Cherry JD: Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to <i>Bordetella pertussis</i> and other <i>Bordetella</i> subspecies. <i>Clin Microbiol Rev.</i> 2005; <b>18</b>(2): 326–82. <a target=xrefwindow id=d9873e1687 href="http://www.ncbi.nlm.nih.gov/pubmed/15831828">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1691 href="http://dx.doi.org/10.1128/CMR.18.2.326-382.2005">Publisher Full Text </a> | <a target=xrefwindow id=d9873e1694 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1082800">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d9873e1703 class=n-a></a>Fedele G, Bianco M, Ausiello CM: The virulence factors of <i>Bordetella pertussis</i>: talented modulators of host immune response. <i>Arch Immunol Ther Exp (Warsz).</i> 2013; <b>61</b>(6): 445–57. <a target=xrefwindow id=d9873e1714 href="http://www.ncbi.nlm.nih.gov/pubmed/23955529">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1717 href="http://dx.doi.org/10.1007/s00005-013-0242-1">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d9873e1726 class=n-a></a>Serra DO, Conover MS, Arnal L, <i> et al.</i>: FHA-mediated cell-substrate and cell-cell adhesions are critical for <i>Bordetella pertussis</i> biofilm formation on abiotic surfaces and in the mouse nose and the trachea. <i>PLoS One.</i> 2011; <b>6</b>(12): e28811. <a target=xrefwindow id=d9873e1740 href="http://www.ncbi.nlm.nih.gov/pubmed/22216115">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1744 href="http://dx.doi.org/10.1371/journal.pone.0028811">Publisher Full Text </a> | <a target=xrefwindow id=d9873e1747 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3245231">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d9873e1756 class=n-a></a>de Melker HE, Versteegh FG, Schellekens JF, <i> et al.</i>: The incidence of <i>Bordetella pertussis</i> infections estimated in the population from a combination of serological surveys. <i>J Infect.</i> 2006; <b>53</b>(2): 106–13. <a target=xrefwindow id=d9873e1770 href="http://www.ncbi.nlm.nih.gov/pubmed/16352342">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1774 href="http://dx.doi.org/10.1016/j.jinf.2005.10.020">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d9873e1783 class=n-a></a>Zhang Q, Yin Z, Li Y, <i> et al.</i>: Prevalence of asymptomatic <i>Bordetella pertussis</i> and <i>Bordetella parapertussis</i> infections among school children in China as determined by pooled real-time PCR: a cross-sectional study. <i>Scand J Infect Dis.</i> 2014; <b>46</b>(4): 280–7. <a target=xrefwindow id=d9873e1801 href="http://www.ncbi.nlm.nih.gov/pubmed/24520981">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1804 href="http://dx.doi.org/10.3109/00365548.2013.878034">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d9873e1813 class=n-a></a>Farizo KM, Cochi SL, Zell ER, <i> et al.</i>: Epidemiological features of pertussis in the United States, 1980–1989. <i>Clin Infect Dis.</i> 1992; <b>14</b>(3): 708–19. <a target=xrefwindow id=d9873e1824 href="http://www.ncbi.nlm.nih.gov/pubmed/1562663">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1827 href="http://dx.doi.org/10.1093/clinids/14.3.708">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d9873e1837 class=n-a></a>Amirthalingam G, Gupta S, Campbell H: Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review. <i>Euro Surveill.</i> 2013; <b>18</b>(38): pii: 20587. <a target=xrefwindow id=d9873e1845 href="http://www.ncbi.nlm.nih.gov/pubmed/24084340">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1848 href="http://dx.doi.org/10.2807/1560-7917.ES2013.18.38.20587">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d9873e1857 class=n-a></a>Murphy JF: Pertussis has re-emerged. <i>Ir Med J.</i> 2012; <b>105</b>(8): 260. <a target=xrefwindow id=d9873e1865 href="http://www.ncbi.nlm.nih.gov/pubmed/23155908">PubMed Abstract </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d9873e1874 class=n-a></a>Sizaire V, Garrido-Estepa M, Masa-Calles J, <i> et al.</i>: Increase of pertussis incidence in 2010 to 2012 after 12 years of low circulation in Spain. <i>Euro Surveill.</i> 2014; <b>19</b>(32): pii: 20875. <a target=xrefwindow id=d9873e1885 href="http://www.ncbi.nlm.nih.gov/pubmed/25139074">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1888 href="http://dx.doi.org/10.2807/1560-7917.ES2014.19.32.20875">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d9873e1897 class=n-a></a>Spokes PJ, Gilmour RE: NSW annual vaccine-preventable disease report, 2010. <i>N S W Public Health Bull.</i> 2011; <b>22</b>(9–10): 171–8. <a target=xrefwindow id=d9873e1905 href="http://www.ncbi.nlm.nih.gov/pubmed/22060055">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1908 href="http://dx.doi.org/10.1071/NB11028">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d9873e1917 class=n-a></a>Quinn HE, McIntyre PB: The impact of adolescent pertussis immunization, 2004–2009: lessons from Australia. <i>Bull World Health Organ.</i> 2011; <b>89</b>(9): 666–74. <a target=xrefwindow id=d9873e1925 href="http://www.ncbi.nlm.nih.gov/pubmed/21897487">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1928 href="http://dx.doi.org/10.2471/BLT.11.086538">Publisher Full Text </a> | <a target=xrefwindow id=d9873e1931 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3165977">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d9873e1940 class=n-a></a>Qin X, Galanakis E, Martin ET, <i> et al.</i>: Multitarget PCR for diagnosis of pertussis and its clinical implications. <i>J Clin Microbiol.</i> 2007; <b>45</b>(2): 506–11. <a target=xrefwindow id=d9873e1951 href="http://www.ncbi.nlm.nih.gov/pubmed/17151210">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1954 href="http://dx.doi.org/10.1128/JCM.02042-06">Publisher Full Text </a> | <a target=xrefwindow id=d9873e1958 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1829034">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d9873e1968 class=n-a></a>Tatti KM, Tondella ML: Utilization of multiple real-time PCR assays for the diagnosis of <i>Bordetella</i> spp. in clinical specimens. <i>Methods Mol Biol.</i> 2013; <b>943</b>: 135–47. <a target=xrefwindow id=d9873e1979 href="http://www.ncbi.nlm.nih.gov/pubmed/23104287">PubMed Abstract </a> | <a target=xrefwindow id=d9873e1982 href="http://dx.doi.org/10.1007/978-1-60327-353-4_9">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d9873e1991 class=n-a></a>Stone BL, Daly J, Srivastava R: Duration of <i>Bordetella pertussis</i> Polymerase Chain Reaction Positivity in Confirmed Pertussis Illness. <i>J Pediatric Infect Dis Soc.</i> 2014; <b>3</b>(4): 347–9. <a target=xrefwindow id=d9873e2002 href="http://www.ncbi.nlm.nih.gov/pubmed/26625456">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2005 href="http://dx.doi.org/10.1093/jpids/piu004">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725427295"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9873e2014 class=n-a></a>Pimentel AM, Baptista PN, Ximenes RA, <i> et al.</i>: Pertussis may be the cause of prolonged cough in adolescents and adults in the interepidemic period. <i>Braz J Infect Dis.</i> 2015; <b>19</b>(1): 43–6. <a target=xrefwindow id=d9873e2025 href="http://www.ncbi.nlm.nih.gov/pubmed/25452019">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2028 href="http://dx.doi.org/10.1016/j.bjid.2014.09.001">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725427295">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d9873e2041 class=n-a></a>Cagney M, McIntyre PB, Heron L, <i> et al.</i>: The relationship between pertussis symptomatology, incidence and serology in adolescents. <i>Vaccine.</i> 2008; <b>26</b>(44): 5547–53. <a target=xrefwindow id=d9873e2052 href="http://www.ncbi.nlm.nih.gov/pubmed/18723066">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2055 href="http://dx.doi.org/10.1016/j.vaccine.2008.08.009">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d9873e2064 class=n-a></a>Public Health England: Incidence of laboratory-confirmed pertussis cases by age group, England 1998–2015. 2016.</span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d9873e2073 class=n-a></a>Public Health England: Whooping cough (pertussis) statistics. <a target=xrefwindow id=d9873e2075 href="https://www.gov.uk/government/publications/whooping-cough-pertussis-statistics">Reference Source</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d9873e2085 class=n-a></a>Centers for Disease Control and Prevention: Childhood Diphtheria toxoid, Tetanus toxoid, acellular Pertussis (DTaP) Vaccination Coverage 2015. Accessed 13 March, 2017. <a target=xrefwindow id=d9873e2087 href="https://www.cdc.gov/vaccines/imz-managers/coverage/childvaxview/data-reports/dtap/reports/2015.html">Reference Source</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d9873e2096 class=n-a></a>Centers for Disease Control and Prevention (CDC): Adult vaccination coverage--United States, 2010. <i>MMWR Morb Mortal Wkly Rep.</i> 2012; <b>61</b>(4): 66–72. <a target=xrefwindow id=d9873e2104 href="http://www.ncbi.nlm.nih.gov/pubmed/22298302">PubMed Abstract </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d9873e2113 class=n-a></a>Glanz JM, McClure DL, Magid DJ, <i> et al.</i>: Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children. <i>Pediatrics.</i> 2009; <b>123</b>(6): 1446–51. <a target=xrefwindow id=d9873e2124 href="http://www.ncbi.nlm.nih.gov/pubmed/19482753">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2127 href="http://dx.doi.org/10.1542/peds.2008-2150">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726218920"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9873e2136 class=n-a></a>Phadke VK, Bednarczyk RA, Salmon DA, <i> et al.</i>: Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis. <i>JAMA.</i> 2016; <b>315</b>(11): 1149–58. <a target=xrefwindow id=d9873e2147 href="http://www.ncbi.nlm.nih.gov/pubmed/26978210">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2150 href="http://dx.doi.org/10.1001/jama.2016.1353">Publisher Full Text </a> | <a target=xrefwindow id=d9873e2154 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5007135">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726218920">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d9873e2167 class=n-a></a>Barreto L, Guasparini R, Meekison W, <i> et al.</i>: Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. <i>Vaccine.</i> 2007; <b>25</b>(48): 8172–9. <a target=xrefwindow id=d9873e2178 href="http://www.ncbi.nlm.nih.gov/pubmed/17945400">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2181 href="http://dx.doi.org/10.1016/j.vaccine.2007.09.031">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d9873e2190 class=n-a></a>Witt MA, Katz PH, Witt DJ: Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. <i>Clin Infect Dis.</i> 2012; <b>54</b>(12): 1730–5. <a target=xrefwindow id=d9873e2198 href="http://www.ncbi.nlm.nih.gov/pubmed/22423127">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2201 href="http://dx.doi.org/10.1093/cid/cis287">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d9873e2211 class=n-a></a>Weston W, Messier M, Friedland LR, <i> et al.</i>: Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine. <i>Vaccine.</i> 2011; <b>29</b>(47): 8483–6. <a target=xrefwindow id=d9873e2222 href="http://www.ncbi.nlm.nih.gov/pubmed/21945698">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2225 href="http://dx.doi.org/10.1016/j.vaccine.2011.09.063">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d9873e2234 class=n-a></a>Giuliano M, Mastrantonio P, Giammanco A, <i> et al.</i>: Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. <i>J Pediatr.</i> 1998; <b>132</b>(6): 983–8. <a target=xrefwindow id=d9873e2245 href="http://www.ncbi.nlm.nih.gov/pubmed/9627590">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2248 href="http://dx.doi.org/10.1016/S0022-3476(98)70395-6">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d9873e2257 class=n-a></a>Giuliano M, Mastrantonio P, Giammanco A, <i> et al.</i>: Antibody kinetics and long-term sero-prevalence in the Italian clinical trial of acellular pertussis vaccines. <i>Dev Biol Stand.</i> 1997; <b>89</b>: 275–8. <a target=xrefwindow id=d9873e2268 href="http://www.ncbi.nlm.nih.gov/pubmed/9272360">PubMed Abstract </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d9873e2277 class=n-a></a>Klein NP, Bartlett J, Rowhani-Rahbar A, <i> et al.</i>: Waning protection after fifth dose of acellular pertussis vaccine in children. <i>N Engl J Med.</i> 2012; <b>367</b>(11): 1012–9. <a target=xrefwindow id=d9873e2288 href="http://www.ncbi.nlm.nih.gov/pubmed/22970945">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2291 href="http://dx.doi.org/10.1056/NEJMoa1200850">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725298684"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9873e2300 class=n-a></a>McGirr A, Fisman DN: Duration of pertussis immunity after DTaP immunization: a meta-analysis. <i>Pediatrics.</i> 2015; <b>135</b>(2): 331–43. <a target=xrefwindow id=d9873e2308 href="http://www.ncbi.nlm.nih.gov/pubmed/25560446">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2311 href="http://dx.doi.org/10.1542/peds.2014-1729">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725298684">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d9873e2324 class=n-a></a>Bart MJ, van Gent M, van der Heide HG, <i> et al.</i>: Comparative genomics of prevaccination and modern <i>Bordetella pertussis</i> strains. <i>BMC Genomics.</i> 2010; <b>11</b>: 627. <a target=xrefwindow id=d9873e2338 href="http://www.ncbi.nlm.nih.gov/pubmed/21070624">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2342 href="http://dx.doi.org/10.1186/1471-2164-11-627">Publisher Full Text </a> | <a target=xrefwindow id=d9873e2345 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3018138">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d9873e2355 class=n-a></a>Bart MJ, Harris SR, Advani A, <i> et al.</i>: Global population structure and evolution of <i>Bordetella pertussis</i> and their relationship with vaccination. <i>MBio.</i> 2014; <b>5</b>(2): e01074. <a target=xrefwindow id=d9873e2369 href="http://www.ncbi.nlm.nih.gov/pubmed/24757216">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2373 href="http://dx.doi.org/10.1128/mBio.01074-14">Publisher Full Text </a> | <a target=xrefwindow id=d9873e2376 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3994516">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d9873e2385 class=n-a></a>Bouchez V, Brun D, Cantinelli T, <i> et al.</i>: First report and detailed characterization of <i>B. pertussis</i> isolates not expressing Pertussis Toxin or Pertactin. <i>Vaccine.</i> 2009; <b>27</b>(43): 6034–41. <a target=xrefwindow id=d9873e2399 href="http://www.ncbi.nlm.nih.gov/pubmed/19666155">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2403 href="http://dx.doi.org/10.1016/j.vaccine.2009.07.074">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725285203"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9873e2412 class=n-a></a>van Gent M, Heuvelman CJ, van der Heide HG, <i> et al.</i>: Analysis of <i>Bordetella pertussis</i> clinical isolates circulating in European countries during the period 1998–2012. <i>Eur J Clin Microbiol Infect Dis.</i> 2015; <b>34</b>(4): 821–30. <a target=xrefwindow id=d9873e2426 href="http://www.ncbi.nlm.nih.gov/pubmed/25527446">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2430 href="http://dx.doi.org/10.1007/s10096-014-2297-2">Publisher Full Text </a> | <a target=xrefwindow id=d9873e2433 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4365279">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725285203">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d9873e2446 class=n-a></a>Zeddeman A, van Gent M, Heuvelman CJ, <i> et al.</i>: Investigations into the emergence of pertactin-deficient <i>Bordetella pertussis</i> isolates in six European countries, 1996 to 2012. <i>Euro Surveill.</i> 2014; <b>19</b>(33): pii: 20881. <a target=xrefwindow id=d9873e2460 href="http://www.ncbi.nlm.nih.gov/pubmed/25166348">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2464 href="http://dx.doi.org/10.2807/1560-7917.ES2014.19.33.20881">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728873032"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9873e2473 class=n-a></a>Bouchez V, Hegerle N, Strati F, <i> et al.</i>: New Data on Vaccine Antigen Deficient <i>Bordetella pertussis</i> Isolates. <i>Vaccines (Basel).</i> 2015; <b>3</b>(3): 751–70. <a target=xrefwindow id=d9873e2487 href="http://www.ncbi.nlm.nih.gov/pubmed/26389958">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2491 href="http://dx.doi.org/10.3390/vaccines3030751">Publisher Full Text </a> | <a target=xrefwindow id=d9873e2494 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4586476">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728873032">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/720887057"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9873e2507 class=n-a></a>Martin SW, Pawloski L, Williams M, <i> et al.</i>: Pertactin-negative <i>Bordetella pertussis</i> strains: evidence for a possible selective advantage. <i>Clin Infect Dis.</i> 2015; <b>60</b>(2): 223–7. <a target=xrefwindow id=d9873e2521 href="http://www.ncbi.nlm.nih.gov/pubmed/25301209">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2525 href="http://dx.doi.org/10.1093/cid/ciu788">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/720887057">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d9873e2539 class=n-a></a>Queenan AM, Cassiday PK, Evangelista A: Pertactin-negative variants of <i>Bordetella pertussis</i> in the United States. <i>N Engl J Med.</i> 2013; <b>368</b>(6): 583–4. <a target=xrefwindow id=d9873e2550 href="http://www.ncbi.nlm.nih.gov/pubmed/23388024">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2553 href="http://dx.doi.org/10.1056/NEJMc1209369">Publisher Full Text </a> | <a target=xrefwindow id=d9873e2557 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5115783">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d9873e2566 class=n-a></a>Locht C, Coutte L, Mielcarek N: The ins and outs of pertussis toxin. <i>FEBS J.</i> 2011; <b>278</b>(23): 4668–82. <a target=xrefwindow id=d9873e2574 href="http://www.ncbi.nlm.nih.gov/pubmed/21740523">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2577 href="http://dx.doi.org/10.1111/j.1742-4658.2011.08237.x">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d9873e2586 class=n-a></a>Advani A, Gustafsson L, Carlsson RM, <i> et al.</i>: Clinical outcome of pertussis in Sweden: association with pulsed-field gel electrophoresis profiles and serotype. <i>APMIS.</i> 2007; <b>115</b>(6): 736–42. <a target=xrefwindow id=d9873e2597 href="http://www.ncbi.nlm.nih.gov/pubmed/17550382">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2600 href="http://dx.doi.org/10.1111/j.1600-0463.2007.apm_628.x">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d9873e2609 class=n-a></a>Hallander HO, Advani A, Donnelly D, <i> et al.</i>: Shifts of <i>Bordetella pertussis</i> variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. <i>J Clin Microbiol.</i> 2005; <b>43</b>(6): 2856–65. <a target=xrefwindow id=d9873e2623 href="http://www.ncbi.nlm.nih.gov/pubmed/15956409">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2627 href="http://dx.doi.org/10.1128/JCM.43.6.2856-2865.2005">Publisher Full Text </a> | <a target=xrefwindow id=d9873e2630 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1151881">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d9873e2639 class=n-a></a>Fine PE, Clarkson JA: The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. <i>Lancet.</i> 1982; <b>1</b>(8273): 666–9. <a target=xrefwindow id=d9873e2647 href="http://www.ncbi.nlm.nih.gov/pubmed/6121976">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2650 href="http://dx.doi.org/10.1016/S0140-6736(82)92214-0">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d9873e2659 class=n-a></a>Edwards KM, Decker MD: Pertussis vaccines. In: Plotkin S, ed. <i>Vaccines</i>. Philadelphia PA: Elsevier; 2013; 447–492. <a target=xrefwindow id=d9873e2664 href="http://dx.doi.org/10.1016/B978-1-4557-0090-5.00030-6">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d9873e2674 class=n-a></a>Cherry JD, Heininger U: Pertussis and other <i>Bordetella</i> infections. <i>Feigin and Cherry’s Textbook of Pediatric Infectious Diseases</i>. Philadelphia, PA: Saunders/Elsevier; 2014; <b>129</b>: 1616–1639.e12. <a target=xrefwindow id=d9873e2685 href="https://www.clinicalkey.com/#!/content/book/3-s2.0-B9781455711772001291">Reference Source</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d9873e2694 class=n-a></a>Rohani P, Earn DJ, Grenfell BT: Impact of immunisation on pertussis transmission in England and Wales. <i>Lancet.</i> 2000; <b>355</b>(9200): 285–6. <a target=xrefwindow id=d9873e2702 href="http://www.ncbi.nlm.nih.gov/pubmed/10675078">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2705 href="http://dx.doi.org/10.1016/S0140-6736(99)04482-7">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d9873e2714 class=n-a></a>Broutin H, Mantilla-Beniers NB, Simondon F, <i> et al.</i>: Epidemiological impact of vaccination on the dynamics of two childhood diseases in rural Senegal. <i>Microbes Infect.</i> 2005; <b>7</b>(4): 593–9. <a target=xrefwindow id=d9873e2725 href="http://www.ncbi.nlm.nih.gov/pubmed/15820150">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2728 href="http://dx.doi.org/10.1016/j.micinf.2004.12.018">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d9873e2737 class=n-a></a>Blackwood JC, Cummings DA, Broutin H, <i> et al.</i>: Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand. <i>Proc Natl Acad Sci U S A.</i> 2013; <b>110</b>(23): 9595–600. <a target=xrefwindow id=d9873e2748 href="http://www.ncbi.nlm.nih.gov/pubmed/23690587">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2751 href="http://dx.doi.org/10.1073/pnas.1220908110">Publisher Full Text </a> | <a target=xrefwindow id=d9873e2755 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3677483">Free Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d9873e2764 class=n-a></a>Domenech de Cellès M, Magpantay FM, King AA, <i> et al.</i>: The pertussis enigma: reconciling epidemiology, immunology and evolution. <i>Proc Biol Sci.</i> 2016; <b>283</b>(1822): pii: 20152309. <a target=xrefwindow id=d9873e2775 href="http://www.ncbi.nlm.nih.gov/pubmed/26763701">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2778 href="http://dx.doi.org/10.1098/rspb.2015.2309">Publisher Full Text </a> | <a target=xrefwindow id=d9873e2782 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4721090">Free Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d9873e2791 class=n-a></a>Gay NJ, Miller E: Pertussis transmission in England and Wales. <i>Lancet.</i> 2000; <b>355</b>(9214): 1553–4. <a target=xrefwindow id=d9873e2799 href="http://www.ncbi.nlm.nih.gov/pubmed/10801196">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2802 href="http://dx.doi.org/10.1016/S0140-6736(05)74603-1">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725757576"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9873e2812 class=n-a></a>Carcione D, Regan AK, Tracey L, <i> et al.</i>: The impact of parental postpartum pertussis vaccination on infection in infants: A population-based study of cocooning in Western Australia. <i>Vaccine.</i> 2015; <b>33</b>(42): 5654–61. <a target=xrefwindow id=d9873e2823 href="http://www.ncbi.nlm.nih.gov/pubmed/26320420">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2826 href="http://dx.doi.org/10.1016/j.vaccine.2015.08.066">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725757576">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d9873e2839 class=n-a></a>Warfel JM, Zimmerman LI, Merkel TJ: Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. <i>Proc Natl Acad Sci U S A.</i> 2014; <b>111</b>(2): 787–92. <a target=xrefwindow id=d9873e2847 href="http://www.ncbi.nlm.nih.gov/pubmed/24277828">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2850 href="http://dx.doi.org/10.1073/pnas.1314688110">Publisher Full Text </a> | <a target=xrefwindow id=d9873e2853 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3896208">Free Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d9873e2862 class=n-a></a>Warfel JM, Merkel TJ: The baboon model of pertussis: effective use and lessons for pertussis vaccines. <i>Expert Rev Vaccines.</i> 2014; <b>13</b>(10): 1241–52. <a target=xrefwindow id=d9873e2870 href="http://www.ncbi.nlm.nih.gov/pubmed/25182980">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2873 href="http://dx.doi.org/10.1586/14760584.2014.946016">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d9873e2882 class=n-a></a>Warfel JM, Papin JF, Wolf RF, <i> et al.</i>: Maternal and neonatal vaccination protects newborn baboons from pertussis infection. <i>J Infect Dis.</i> 2014; <b>210</b>(4): 604–10. <a target=xrefwindow id=d9873e2893 href="http://www.ncbi.nlm.nih.gov/pubmed/24526741">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2896 href="http://dx.doi.org/10.1093/infdis/jiu090">Publisher Full Text </a> | <a target=xrefwindow id=d9873e2900 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4133576">Free Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725953914"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9873e2909 class=n-a></a>Warfel JM, Zimmerman LI, Merkel TJ: Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis. <i>Clin Vaccine Immunol.</i> 2015; <b>23</b>(1): 47–54. <a target=xrefwindow id=d9873e2917 href="http://www.ncbi.nlm.nih.gov/pubmed/26561389">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2920 href="http://dx.doi.org/10.1128/CVI.00449-15">Publisher Full Text </a> | <a target=xrefwindow id=d9873e2923 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4711092">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725953914">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d9873e2936 class=n-a></a>Préziosi MP, Halloran ME: Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness. <i>Vaccine.</i> 2003; <b>21</b>(17–18): 1853–61. <a target=xrefwindow id=d9873e2944 href="http://www.ncbi.nlm.nih.gov/pubmed/12706669">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2947 href="http://dx.doi.org/10.1016/S0264-410X(03)00007-0">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d9873e2957 class=n-a></a>Mosmann TR, Cherwinski H, Bond MW, <i> et al.</i>: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. <i>J Immunol.</i> 1986; <b>136</b>(7): 2348–57. <a target=xrefwindow id=d9873e2968 href="http://www.ncbi.nlm.nih.gov/pubmed/2419430">PubMed Abstract </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d9873e2977 class=n-a></a>Khader SA, Gaffen SL, Kolls JK: Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. <i>Mucosal Immunol.</i> 2009; <b>2</b>(5): 403–11. <a target=xrefwindow id=d9873e2985 href="http://www.ncbi.nlm.nih.gov/pubmed/19587639">PubMed Abstract </a> | <a target=xrefwindow id=d9873e2988 href="http://dx.doi.org/10.1038/mi.2009.100">Publisher Full Text </a> | <a target=xrefwindow id=d9873e2991 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2811522">Free Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d9873e3000 class=n-a></a>Ross PJ, Sutton CE, Higgins S, <i> et al.</i>: Relative contribution of Th1 and Th17 cells in adaptive immunity to <i>Bordetella pertussis</i>: towards the rational design of an improved acellular pertussis vaccine. <i>PLoS Pathog.</i> 2013; <b>9</b>(4): e1003264. <a target=xrefwindow id=d9873e3014 href="http://www.ncbi.nlm.nih.gov/pubmed/23592988">PubMed Abstract </a> | <a target=xrefwindow id=d9873e3018 href="http://dx.doi.org/10.1371/journal.ppat.1003264">Publisher Full Text </a> | <a target=xrefwindow id=d9873e3021 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3617212">Free Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d9873e3030 class=n-a></a>Higgs R, Higgins SC, Ross PJ, <i> et al.</i>: Immunity to the respiratory pathogen <i>Bordetella pertussis</i>. <i>Mucosal Immunol.</i> 2012; <b>5</b>(5): 485–500. <a target=xrefwindow id=d9873e3044 href="http://www.ncbi.nlm.nih.gov/pubmed/22718262">PubMed Abstract </a> | <a target=xrefwindow id=d9873e3048 href="http://dx.doi.org/10.1038/mi.2012.54">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d9873e3057 class=n-a></a>Warfel JM, Merkel TJ: <i>Bordetella pertussis</i> infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. <i>Mucosal Immunol.</i> 2013; <b>6</b>(4): 787–96. <a target=xrefwindow id=d9873e3068 href="http://www.ncbi.nlm.nih.gov/pubmed/23187316">PubMed Abstract </a> | <a target=xrefwindow id=d9873e3071 href="http://dx.doi.org/10.1038/mi.2012.117">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d9873e3080 class=n-a></a>Watanabe M, Nagai M: Acellular pertussis vaccines in Japan: past, present and future. <i>Expert Rev Vaccines.</i> 2005; <b>4</b>(2): 173–84. <a target=xrefwindow id=d9873e3088 href="http://www.ncbi.nlm.nih.gov/pubmed/15889991">PubMed Abstract </a> | <a target=xrefwindow id=d9873e3091 href="http://dx.doi.org/10.1586/14760584.4.2.173">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728882150"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9873e3101 class=n-a></a>Carlsson RM, von Segebaden K, Bergstrom J, <i> et al.</i>: Surveillance of infant pertussis in Sweden 1998–2012; severity of disease in relation to the national vaccination programme. <i>Euro Surveill.</i> 2015; <b>20</b>(6): pii: 21032. <a target=xrefwindow id=d9873e3112 href="http://www.ncbi.nlm.nih.gov/pubmed/25695476">PubMed Abstract </a> | <a target=xrefwindow id=d9873e3115 href="http://dx.doi.org/10.2807/1560-7917.ES2015.20.6.21032">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728882150">F1000 Recommendation</a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d9873e3128 class=n-a></a>Gonfiantini MV, Carloni E, Gesualdo F, <i> et al.</i>: Epidemiology of pertussis in Italy: disease trends over the last century. <i>Euro Surveill.</i> 2014; <b>19</b>(40): 20921. <a target=xrefwindow id=d9873e3139 href="http://www.ncbi.nlm.nih.gov/pubmed/25323077">PubMed Abstract </a> | <a target=xrefwindow id=d9873e3142 href="http://dx.doi.org/10.2807/1560-7917.ES2014.19.40.20921">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d9873e3151 class=n-a></a>Domenech de Cellès M, Riolo MA, Magpantay FM, <i> et al.</i>: Epidemiological evidence for herd immunity induced by acellular pertussis vaccines. <i>Proc Natl Acad Sci U S A.</i> 2014; <b>111</b>(7): E716–7. <a target=xrefwindow id=d9873e3162 href="http://www.ncbi.nlm.nih.gov/pubmed/24516173">PubMed Abstract </a> | <a target=xrefwindow id=d9873e3165 href="http://dx.doi.org/10.1073/pnas.1323795111">Publisher Full Text </a> | <a target=xrefwindow id=d9873e3169 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3932918">Free Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d9873e3178 class=n-a></a>Trollfors B, Taranger J, Lagergård T, <i> et al.</i>: Immunization of children with pertussis toxoid decreases spread of pertussis within the family. <i>Pediatr Infect Dis J.</i> 1998; <b>17</b>(3): 196–9. <a target=xrefwindow id=d9873e3189 href="http://www.ncbi.nlm.nih.gov/pubmed/9535245">PubMed Abstract </a> | <a target=xrefwindow id=d9873e3192 href="http://dx.doi.org/10.1097/00006454-199803000-00005">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d9873e3201 class=n-a></a>Carlsson RM, Trollfors B: Control of pertussis--lessons learnt from a 10-year surveillance programme in Sweden. <i>Vaccine.</i> 2009; <b>27</b>(42): 5709–18. <a target=xrefwindow id=d9873e3209 href="http://www.ncbi.nlm.nih.gov/pubmed/19679218">PubMed Abstract </a> | <a target=xrefwindow id=d9873e3212 href="http://dx.doi.org/10.1016/j.vaccine.2009.07.092">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d9873e3221 class=n-a></a>Warfel JM, Beren J, Merkel TJ: Airborne transmission of <i>Bordetella pertussis</i>. <i>J Infect Dis.</i> 2012; <b>206</b>(6): 902–6. <a target=xrefwindow id=d9873e3232 href="http://www.ncbi.nlm.nih.gov/pubmed/22807521">PubMed Abstract </a> | <a target=xrefwindow id=d9873e3235 href="http://dx.doi.org/10.1093/infdis/jis443">Publisher Full Text </a> | <a target=xrefwindow id=d9873e3239 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3501154">Free Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d9873e3249 class=n-a></a>Meade BD, Plotkin SA, Locht C: Possible options for new pertussis vaccines. <i>J Infect Dis.</i> 2014; <b>209 Suppl 1</b>: S24–7. <a target=xrefwindow id=d9873e3257 href="http://www.ncbi.nlm.nih.gov/pubmed/24626868">PubMed Abstract </a> | <a target=xrefwindow id=d9873e3260 href="http://dx.doi.org/10.1093/infdis/jit531">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d9873e3269 class=n-a></a>Plotkin SA: The pertussis problem. <i>Clin Infect Dis.</i> 2014; <b>58</b>(6): 830–3. <a target=xrefwindow id=d9873e3277 href="http://www.ncbi.nlm.nih.gov/pubmed/24363332">PubMed Abstract </a> | <a target=xrefwindow id=d9873e3280 href="http://dx.doi.org/10.1093/cid/cit934">Publisher Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d9873e3289 class=n-a></a>Mills KH, Ross PJ, Allen AC, <i> et al.</i>: Do we need a new vaccine to control the re-emergence of pertussis? <i>Trends Microbiol.</i> 2014; <b>22</b>(2): 49–52. <a target=xrefwindow id=d9873e3300 href="http://www.ncbi.nlm.nih.gov/pubmed/24485284">PubMed Abstract </a> | <a target=xrefwindow id=d9873e3303 href="http://dx.doi.org/10.1016/j.tim.2013.11.007">Publisher Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727488093"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9873e3312 class=n-a></a>Locht C: Live pertussis vaccines: will they protect against carriage and spread of pertussis? <i>Clin Microbiol Infect.</i> 2016; <b>22 Suppl 5</b>: S96–S102. <a target=xrefwindow id=d9873e3320 href="http://www.ncbi.nlm.nih.gov/pubmed/28341014">PubMed Abstract </a> | <a target=xrefwindow id=d9873e3323 href="http://dx.doi.org/10.1016/j.cmi.2016.05.029">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727488093">F1000 Recommendation</a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d9873e3336 class=n-a></a>Siddiqui M, Salmon DA, Omer SB: Epidemiology of vaccine hesitancy in the United States. <i>Hum Vaccin Immunother.</i> 2013; <b>9</b>(12): 2643–8. <a target=xrefwindow id=d9873e3344 href="http://www.ncbi.nlm.nih.gov/pubmed/24247148">PubMed Abstract </a> | <a target=xrefwindow id=d9873e3347 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4162046">Free Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 25 Aug 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1568.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1568.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Centre for Global Health and Development , Boston University School of Public Health, Boston, Massachusetts, 02118, USA<br/> <sup>2</sup> Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, 02118, USA<br/> <sup>3</sup> Department of Infectious Diseases College of Veterinary Medicine, Odum School of Ecology , University of Georgia, Athens, Georgia, 30602, USA<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-1568/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 25 Aug 2017, 6:1568 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11654.1">https://doi.org/10.12688/f1000research.11654.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Gill CJ <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=12588 data-id=11654 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11654.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-1568/v1/pdf?article_uuid=5d1ff47b-1f1d-4ed8-8951-bfbb1888e418" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11654.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Gill CJ, Rohani P and Thea DM. The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of <i>Bordetella pertussis</i> [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1568 (<a href="https://doi.org/10.12688/f1000research.11654.1" target=_blank>https://doi.org/10.12688/f1000research.11654.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11654 id=mobile-track-article-signin-11654 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11654?target=/articles/6-1568.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12588 /> <input name=articleId type=hidden value=11654 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Camille Locht</strong>, Center for Infection and Immunity of Lille, Institut Pasteur de Lille, France </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Erik L Hewlett</strong>, Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 25 Aug 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1568.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1568.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=25495-25384></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=25342-25385></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-1568/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>25 Aug 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Camille Locht</strong>, Center for Infection and Immunity of Lille, Institut Pasteur de Lille, France </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Erik L Hewlett</strong>, Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-1568.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-1568/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "The relationship between mucosal immunity,...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-1568/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-1568/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-1568/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Gill CJ et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-1568/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-1568",
            templates : {
                twitter : "The relationship between mucosal immunity, nasopharyngeal carriage,.... Gill CJ et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-1568/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11654/12588")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "12588");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "25384": 0,
                           "25385": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "d7d0d438-c6c3-4f0f-a6b5-0317905ba02e";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1568.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1568.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1568.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-1568.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-1568.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>